D. Waters

发表

Effects of torcetrapib in patients at high risk for coronary events.

M. Caulfield, S. Grundy, P. Barter, 2007, The New England journal of medicine.

Latest Results from NEMO-3 & Status of the SuperNEMO Experiment

D. Waters, Nemo, SuperNEMO collaborations, 2017 .

Prognostic importance of scintigraphic left ventricular cavity dilation during intravenous dipyridamole technetium-99m sestamibi myocardial tomographic imaging in predicting coronary events.

D. Waters, J. Gallagher, G. Heller, 1997, The American journal of cardiology.

Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus Revascularization Treatment Investigators.

D. Waters, B. Pitt, D. Eisenberg, 1999, The New England journal of medicine.

Measurements of inclusive W and Z cross sections in p\overline{p} collisions at \sqrt{s} = 1\hbox{.}96\, {{\rm TeV}}

D. Whiteson, M. Feindt, J. Adelman, 2007 .

Volume IV. The DUNE far detector single-phase technology

Jorge S. Díaz, V. P. Luzio, J. I. Crespo-Anadón, 2020, Journal of Instrumentation.

The Single-Phase ProtoDUNE Technical Design Report

D. P. Méndez, F. R. Torres, J. I. Crespo-Anad'on, 2017, 1706.07081.

Neutrino interaction classification with a convolutional neural network in the DUNE far detector

J. I. Crespo-Anad'on, V. P. Luzio, P. Baldi, 2020, Physical Review D.

Volume I. Introduction to DUNE

V. P. Luzio, J. I. Crespo-Anadón, P. Baldi, 2020, Journal of Instrumentation.

Model-independent and quasi-model-independent search for new physics at CDF

D. Whiteson, V. Ramakrishnan, M. Feindt, 2008 .

Simulation of ultra high energy neutrino induced showers in ice and water

D. Waters, L. Thompson, T. Sloan, 2007 .

Study of the acoustic signature of UHE neutrino interactions in water and ice

O. Veledar, D. Waters, L. Thompson, 2009, 0903.0949.

[Formula presented] Production and Polarization in [Formula presented] Collisions at [Formula presented]

M. Spiropulu, M. Albrow, D. Amidei, 2002 .

Cross section for forward j/ψ production in pp collisions at √s=1.8 tev

M. Spiropulu, M. Albrow, D. Amidei, 2002 .

Upsilon production and polarization in p p macro collisions at square root of s = 1.8 TeV.

M. Spiropulu, M. Albrow, D. Amidei, 2002, Physical review letters.

First results on ProtoDUNE-SP liquid argon time projection chamber performance from a beam test at the CERN Neutrino Platform

V. P. Luzio, J. I. Crespo-Anadón, P. Baldi, 2020, Journal of Instrumentation.

The effect of statin therapy on heart failure events: a collaborative meta-analysis of unpublished data from major randomized trials

B. Davis, S. Solomon, P. Ridker, 2015, European heart journal.

Clinical Characteristics Associated with Sudden Death in Patients with Variant Angina

D. Waters, D. Miller, J. Szlachcic, 1982, Circulation.

Comparison of acute rest myocardial perfusion imaging and serum markers of myocardial injury in patients with chest pain syndromes

D. Waters, A. Wu, G. Heller, 1999, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

Measuring progression and regression of coronary atherosclerosis in clinical trials: problems and progress

D. Waters, J. Lespérance, Jacques Lespérance, 2005, The International Journal of Cardiac Imaging.

Evolution of Coronary Atherosclerosis

D. Waters, J. Lespérance, J. Lésperance, 2005 .

Calcium channel blockers and coronary atherosclerosis: from the rabbit to the real world.

D. Waters, J. Lespérance, J. Lésperance, 1994, American heart journal.

Inflammation, Statin Therapy, and Risk of Stroke After an Acute Coronary Syndrome in the MIRACL Study

Nader Rifai, Michael Szarek, Peter Libby, 2007, Arteriosclerosis, thrombosis, and vascular biology.

The BARI Protocol V-3 No CAD Sgle VD Prior Procedure Congenita Heart Disease Valvular Heat Die Prmary Myocardial Disease Age 280 years Left Main Disease Insudfcent Symptoms Emergency Revasc

B. Gersh, D. Waters, 2005 .

Usefulness of heart rate at rest as a predictor of mortality, hospitalization for heart failure, myocardial infarction, and stroke in patients with stable coronary heart disease (Data from the Treating to New Targets [TNT] trial).

D. Waters, P. Deedwania, A. Breazna, 2010, The American journal of cardiology.

Long-baseline neutrino oscillation physics potential of the DUNE experiment

J. I. Crespo-Anad'on, V. P. Luzio, P. Baldi, 2020, The European Physical Journal C.

The DUNE Far Detector Interim Design Report Volume 1: Physics, Technology and Strategies

R. Hatcher, G. N. Perdue, R. Illingworth, 2018, 1807.10334.

Long-Baseline Neutrino Facility (LBNF) and Deep Underground Neutrino Experiment (DUNE) Conceptual Design Report Volume 1: The LBNF and DUNE Projects

R. Hatcher, G. N. Perdue, A. Rappoldi, 2016 .

Calcium Antagonists

D. Waters, P. Théroux, Y. Taeymans, 1983, Drugs.

Clinical manifestations and pathophysiology of myocardial ischemia with special reference to coronary artery spasm and the role of slow channel calcium blockers.

D. Waters, P. Théroux, J. Latour, 1982, Progress in cardiovascular diseases.

Deep Underground Neutrino Experiment (DUNE), Far Detector Technical Design Report, Volume II: DUNE Physics

R. Hatcher, R. Illingworth, A. Rappoldi, 2020, 2002.03005.

Prospects for beyond the Standard Model physics searches at the Deep Underground Neutrino Experiment

J. I. Crespo-Anad'on, V. P. Luzio, P. Baldi, 2020, The European physical journal. C, Particles and fields.

HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials

Hynek Pikhart, Bengt Sennblad, Tom R. Gaunt, 2015, The Lancet.

Tribulations of Recent Cardiology Trials, the Audacity of Hope, and HOPE-3.

D. Waters, K. Chau, 2016, The Canadian journal of cardiology.

Increased carotid intima-media thickness in HIV patients is associated with increased cytomegalovirus-specific T-cell responses

Jeffrey N. Martin, D. Waters, J. McCune, 2006, AIDS.

Measurement of ratios of fragmentation fractions for bottom hadrons in p(p)over-bar collisions at root s=1.96 TeV

D. Whiteson, V. Ramakrishnan, M. Feindt, 2008 .

Search for heavy, long-lived neutralinos that decay to photons at CDF II using photon timing

D. Whiteson, V. Ramakrishnan, M. Feindt, 2008 .

Observation ofBs0→ψ(2S)ϕand Measurement of the Ratio of Branching FractionsB(Bs0→ψ(2S)ϕ)/B(Bs0→J/ψϕ)

D. Whiteson, M. Feindt, J. Adelman, 2006 .

Search for ZZ and ZW production in pp(-) collisions at root s=1.96 TeV RID C-1693-2008 RID G-1087-2011 RID E-4473-2011

Krutelyov, Rekovic, Khotilovich, 2005 .

Effects of cholesterol lowering on the progression of coronary atherosclerosis in women. A Canadian Coronary Atherosclerosis Intervention Trial (CCAIT) substudy.

D. Waters, L. Higginson, J. Lespérance, 1995, Circulation.

Identification of coronary thrombus with a IIb/IIIa platelet inhibitor radiopharmaceutical, technetium-99m DMP-444: A canine model.

D. Waters, G. Heller, M. White, 2000, Circulation.

Circadian variation in variant angina.

D. Waters, D. Miller, P. Théroux, 1984, The American journal of cardiology.

Soft and hard interactions in pp̅ collisions at √s =1800 and 630 GeV

M. Spiropulu, M. Albrow, D. Amidei, 2001 .

Effects of 1-H-indole-3-glyoxamide (A-002) on concentration of secretory phospholipase A2 (PLASMA study): a phase II double-blind, randomised, placebo-controlled trial

D. Waters, R. Rosenson, D. McConnell, 2009, The Lancet.

Effects of varespladib methyl on biomarkers and major cardiovascular events in acute coronary syndrome patients.

D. Waters, R. Rosenson, Y. Stasiv, 2010, Journal of the American College of Cardiology.

Inhibition of Secretory Phospholipase A2 in Patients with Acute Coronary Syndromes: Rationale and Design of the Vascular Inflammation Suppression to Treat Acute Coronary Syndrome for 16 Weeks (VISTA-16) Trial

J. Kastelein, D. Waters, R. Rosenson, 2012, Cardiovascular Drugs and Therapy.

Coronary angioplasty induces a systemic inflammatory response.

D. Waters, A. Wu, R. McKay, 1997, The American journal of cardiology.

Study of substructure of high transverse momentum jets produced in proton-antiproton collisions at √s=1.96TeV

M. Dorigo, D. Whiteson, V. Ramakrishnan, 2011 .

The DUNE Far Detector Interim Design Report, Volume 3: Dual-Phase Module

D. P. Méndez, J. I. Crespo-Anad'on, V. P. Luzio, 2018, 1807.10340.

First results on ProtoDUNE-SP liquid argon time projection chamber performance from a beam test at the CERN Neutrino Platform

V. P. Luzio, J. I. Crespo-Anadón, P. Baldi, 2020, 2007.06722.

Deep Underground Neutrino Experiment (DUNE), Far Detector Technical Design Report, Volume IV Far Detector Single-phase Technology

V. P. Luzio, J. I. Crespo-Anadón, P. Baldi, 2020, 2002.03010.

Efficacy and Safety of Alirocumab 150 mg Every 4 Weeks in Patients With Hypercholesterolemia Not on Statin Therapy: The ODYSSEY CHOICE II Study

Jennifer G. Robinson, J. D. Jordan, G. Molenberghs, 2016, Journal of the American Heart Association.

Early statin therapy in acute coronary syndromes: the successful cycle of evidence, guidelines, and implementation.

D. Waters, Ivy A. Ku, 2009, Journal of the American College of Cardiology.

What the statin trials have taught us.

D. Waters, 2006, The American journal of cardiology.

Safety of high-dose atorvastatin therapy.

D. Waters, 2005, The American journal of cardiology.

Intensive lipid lowering with atorvastatin in patients with stable coronary disease.

A. Gotto, S. Grundy, P. Barter, 2005, New England Journal of Medicine.

Reassessment of National Cholesterol Education Program Adult Treatment Panel-III guidelines: one year later.

D. Waters, B. Ansell, 2002, The American journal of cardiology.

Low-density-lipoprotein cholesterol goals for patients with coronary disease: treating between the lines.

D. Waters, P. Hsue, 2001, Circulation.

Effects of estrogen replacement on the progression of coronary-artery atherosclerosis.

D. Reboussin, C. Furberg, D. Waters, 2000, The New England journal of medicine.

Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: a randomized controlled trial.

J. Hsia, M. Proschan, D. Gordon, 2002, JAMA.

Precision measurement of the top-quark mass from dilepton events at CDF II

D. Whiteson, M. Feindt, J. Adelman, 2007 .

Methylene blue inhibits the antithrombotic effect of nitroglycerin.

D. Waters, L. Lacoste, J. Lam, 1993, Journal of the American College of Cardiology.

Effects of thrombocytopenia and shear rate on neutrophil and platelet deposition on endothelial and medial arterial surfaces.

R. Guidoin, D. Waters, L. Lacoste, 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

Influence of fibrinolysis and percutaneous transluminal coronary angioplasty on the frequency of ventricular premature complexes.

D. Waters, P. Théroux, M. Juneau, 1989, The American journal of cardiology.

Restenosis and progression of coronary atherosclerosis after coronary angioplasty.

D. Waters, J. Lespérance, P. Joly, 1988, Journal of the American College of Cardiology.

PATHOPHYSIOLOGY AND NATURAL HISTORY

D. Waters, P. Théroux, X. Bosch, 2005 .

Is progression of coronary artery disease occurring at bouts or as a continuous process? Serial cineangiographic studies in 44 patients.

D. Waters, P. Théroux, J. Lespérance, 1984, Computers and biomedical research, an international journal.

Effect of High-Dose Atorvastatin on Hospitalizations for Heart Failure: Subgroup Analysis of the Treating to New Targets (TNT) Study

D. Waters, K. Khush, P. Deedwania, 2007, Circulation.

Contrasting Influences of Alterations in Ventricular Preload and Afterload Upon Systemic Hemodynamics, Function, and Metabolism of Ischemic Myocardium

D. Waters, J. Forrester, P. D. da Luz, 1977, Circulation.

Safety of dipyridamole testing in 73,806 patients: The Multicenter Dipyridamole Safety Study

J. Leppo, S. Nattel, D. Waters, 1995, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

Measurement of the $W$ boson polarization in top decay at {CDF} at $\sqrt{s} = 1.8$ TeV

M. Spiropulu, M. Albrow, D. Amidei, 2005 .

Search for V plus A current in top-quark decays in p(p)over-bar collisions root s=1.96 TeV

D. Whiteson, M. Feindt, J. Adelman, 2007 .

Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)

R. Diaz, J. López-Sendón, J. Tardif, 2020, European heart journal.

Nitroglycerin enhances the ability of dobutamine stress echocardiography to detect hibernating myocardium.

D. Waters, L. Gillam, L. Ma, 1997, Circulation.

Vitamin D levels do not predict cardiovascular events in statin-treated patients with stable coronary disease.

D. Waters, N. Wenger, D. Demicco, 2012, American heart journal.

Prediction of cardiovascular events in statin-treated stable coronary patients by lipid and nonlipid biomarkers.

S. Grundy, P. Barter, D. Waters, 2011, Journal of the American College of Cardiology.

Impact of smoking on cardiovascular events in patients with coronary disease receiving contemporary medical therapy (from the Treating to New Targets [TNT] and the Incremental Decrease in End Points Through Aggressive Lipid Lowering [IDEAL] trials).

D. Waters, A. Breazna, D. Demicco, 2011, The American journal of cardiology.

Evidence for a bottom baryon resonance Λ[*0 over b] in CDF data

M. Dorigo, D. Whiteson, T. Aaltonen, 2013 .

Search for $B_s \rightarrow \mu^{+}\mu^{-}$ and $B_d \rightarrow \mu^{+}\mu^{-}$ decays with the full CDF Run II data set

Ji Eun Kim, D. Whiteson, T. Aaltonen, 2013, 1301.7048.

Measurement of the branching fraction B(Λb0→Λc+π-π+π-) at CDF

M. Dorigo, D. Whiteson, V. Ramakrishnan, 2012 .

Search for $B_s \to \mu^+\mu^-$ and $B_d \to \mu^+\mu^-$ Decays with CDF II

Neubauer, M. Dorigo, D. Whiteson, 2011 .

Local delivery of c-myb antisense oligonucleotides during balloon angioplasty.

D. Waters, L. Bow, T. Aretz, 1997, Catheterization and cardiovascular diagnosis.

Search for Gluinos and Scalar Quarks in pp̅ Collisions at √s = 1.8 TeV Using the Missing Energy plus Multijets Signature

Shapiro, M. Spiropulu, M. Albrow, 2002 .

Search for new particles leading to Z+jets final states in pp̄ collisions at s=1.96TeV

Krutelyov, Rekovic, Khotilovich, 2007, 0706.3264.

Estrogen therapy for unstable angina: another bump for the bandwagon.

D. Waters, 2002, Journal of the American College of Cardiology.

Search for Long-Lived Charged Massive Particles in [Formula presented] Collisions at [Formula presented]

M. Spiropulu, M. Albrow, D. Amidei, 2003 .

Measurement of the dipion mass spectrum in X(3872)-> J/psi pi(+)pi(-) decays RID C-1693-2008 RID G-1087-2011 RID E-4473-2011

Krutelyov, Rekovic, Khotilovich, 2006 .

Production of Λ[superscript 0], Λ̅ [superscript 0], Ξ[superscript ±], and Ω[superscript ±] hyperons in pp̅ collisions at √s=1.96 TeV

D. Whiteson, V. Ramakrishnan, M. Feindt, 2012 .

The Evolution of Myocardial Infarction: When the Truths We Hold To Be Self-Evident No Longer Have Evidence.

D. Waters, S. Bangalore, 2017, The Canadian journal of cardiology.

Body Weight Variability and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus

D. Waters, S. Bangalore, D. Demicco, 2018, Circulation. Cardiovascular quality and outcomes.

Tobacco smoke and cardiovascular risk: a call for continued efforts to reduce exposure

D. Waters, Paul Frey, 2011, Current opinion in cardiology.

On‐treatment lipoprotein components and risk of cerebrovascular events in the Treating to New Targets study

D. Waters, I. Holme, J. Kastelein, 2011, European journal of clinical investigation.

Treatment of intracoronary thrombus with local urokinase infusion using a new, site-specific drug delivery system: the Dispatch catheter.

D. Waters, M. Rinaldi, J. Hirst, 1994, Catheterization and cardiovascular diagnosis.

Decreased Platelet Deposition and Smooth Muscle Cell Proliferation After Intramural Heparin Delivery With Hydrogel‐Coated Balloons

D. Waters, L. Bow, J. Barry, 1994, Circulation.

Localized intramural drug delivery during balloon angioplasty using hydrogel-coated balloons and pressure-augmented diffusion.

D. Waters, H. Samady, L. Gillam, 1994, Journal of the American College of Cardiology.

Enhanced intracoronary thrombolysis with urokinase using a novel, local drug delivery system. In vitro, in vivo, and clinical studies.

D. Waters, L. Bow, J. Hirst, 1995, Circulation.

Inhibition of platelet deposition and lysis of intracoronary thrombus during balloon angioplasty using urokinase-coated hydrogel balloons.

D. Waters, L. Bow, S. C. Wong, 1994, Circulation.

Triglyceride-Rich Lipoprotein Cholesterol and Risk of Cardiovascular Events Among Patients Receiving Statin Therapy in the TNT Trial

P. Barter, D. Waters, J. Kastelein, 2018, Circulation.

PCSK9 Inhibition to Lower LDL-Cholesterol and Reduce Cardiovascular Risk: Great Expectations.

D. Waters, P. Hsue, 2015, Circulation research.

Effect of change in body weight on incident diabetes mellitus in patients with stable coronary artery disease treated with atorvastatin (from the treating to new targets study).

P. Barter, D. Waters, D. Demicco, 2014, The American journal of cardiology.

Clinical insights from the Treating to New Targets trial.

D. Waters, 2009, Progress in cardiovascular diseases.

Low- and high-density lipoprotein cholesterol goal attainment in dyslipidemic women: The Lipid Treatment Assessment Project (L-TAP) 2.

D. Waters, J. Jukema, J. Ferrières, 2009, American heart journal.

Effects of high-dose atorvastatin on cerebrovascular events in patients with stable coronary disease in the TNT (treating to new targets) study.

A. Gotto, S. Grundy, P. Barter, 2006, Journal of the American College of Cardiology.

Measurements of inclusive W and Z cross sections in collisions at

D. Whiteson, M. Feindt, J. Adelman, 2007 .

Is a mechanical or a metabolic approach superior in the treatment of coronary disease? Results of the atorvastatin versus revascularization (AVERT) trial.

D. Waters, 2000, European heart journal.

Implications of cigarette smoking for the management of patients with acute coronary syndromes.

D. Waters, Louise D. Metz, 2003, Progress in cardiovascular diseases.

Notes From the Cardiology Clinic: Facing Down the Dragons of Health Anxiety.

D. Waters, 2020, The Canadian journal of cardiology.

Women's Ischemic Syndrome Evaluation: current status and future research directions: report of the National Heart, Lung and Blood Institute workshop: October 2-4, 2002: executive summary.

L. Shaw, T. Manolio, R. Balaban, 2004, Circulation.

The effects of hydroxy-methyl-glutaryl co-enzyme A reductase inhibitors on platelet thrombus formation.

P. Thompson, D. Waters, C. White, 2002, Atherosclerosis.

Canadian coronary atherosclerosis study on the effect of lovastatin on the progression of coronary artery disease (CCAIT): why are results different?

D. Waters, J. Lespérance, L. Campeau, 1996 .

Regression of coronary atherosclerosis: an achievable goal? Review of results from recent clinical trials.

D. Waters, J. Lespérance, J. Lésperance, 1991, The American journal of medicine.

Role of thrombotic and fibrinolytic factors in acute coronary syndromes.

D. Waters, P. Hsue, M. Saigo, 2004, Progress in cardiovascular diseases.

Soluble fibrin, C-reactive protein, fibrinogen, factor VII, antithrombin, proteins C and S, tissue factor, D-dimer, and prothrombin fragment 1 + 2 in men with acute myocardial infarction

D. Waters, C. Tei, I. Maruyama, 2004, The American journal of cardiology.

The Atorvastatin/Donepezil in Alzheimer’s Disease Study (LEADe): Design and baseline characteristics ⁎ ⁎ Roy W. Jones and Miia Kivipelto contributed equally to the content of the manuscript.

Miia Kivipelto, Howard Feldman, Rachelle Doody, 2008, Alzheimer's & Dementia.

Erratum: Measurement of thett¯production cross section inpp¯collisions ats=1.8TeV[Phys. Rev. D64, 032002 (2001)]

A. Ribon, Stephen R. Leone, William Trischuk, 2003 .

An additional study of multi-muon events produced in pp¯ collisions at s=1.96 TeV

M. Dorigo, V. Ramakrishnan, T. Aaltonen, 2012 .

Diffractive dijet production in p¯p collisions at s=1.96 TeV

M. Dorigo, D. Whiteson, V. Ramakrishnan, 2012 .

Measurements of branching fraction ratios and CP-asymmetries in suppressed B-→ D(→ K+π-)K- and B-→ D(→ K+π-)π- decays

M. Dorigo, D. Whiteson, V. Ramakrishnan, 2011 .

Measurement of correlated bb̄ production in pp̄ collisions at s=1960GeV

D. Whiteson, V. Ramakrishnan, M. Feindt, 2008 .

Direct Photon Cross Section with Conversions at Cdf

M. Spiropulu, M. Albrow, D. Amidei, 2008 .

Momentum distribution of charged particles in jets in dijet events in [Formula Presented] collisions at [Formula Presented] and comparisons to perturbative QCD predictions

G. P. Yeh, M. Spiropulu, M. Albrow, 2003 .

Search for Radiative B-Hadron Decays in $p\bar{p}$ Collisions at $\sqrt{s}$ = 1.8 TeV

Shapiro, M. Spiropulu, M. Albrow, 2002 .

Branching ratio measurements of exclusive B+ decays to charmonium with the Collider Detector at Fermilab

G. P. Yeh, Shapiro, M. Spiropulu, 2002 .

Measurement of dσ/dy for high mass Drell-Yan e+e- pairs from pp̄ collisions at √s = 1.8 TeV

M. Spiropulu, M. Albrow, D. Amidei, 2000 .

Measurement of the cross section for direct-photon production in association with a heavy quark in pp¯ collisions at s√ = 1.96 TeV

D. Whiteson, T. Aaltonen, S. Amerio, 2013 .

Measurements of the top-quark mass using charged particle tracking

D. Whiteson, V. Ramakrishnan, M. Feindt, 2010 .

Inflammation in Cardiovascular Disease: From Basic Concepts to Clinical Application

D. Waters, 2020, International Journal of Cardiovascular Sciences.

Comparison of effectiveness of atorvastatin 10 mg versus 80 mg in reducing major cardiovascular events and repeat revascularization in patients with previous percutaneous coronary intervention (post hoc analysis of the Treating to New Targets [TNT] Study).

S. Grundy, D. Waters, A. Breazna, 2008, The American journal of cardiology.

Oral estrogen improves serum lipids, homocysteine and fibrinolysis in elderly men.

P. Thompson, D. Waters, A. Wu, 1998, Atherosclerosis.

Recanalization of totally occluded saphenous vein grafts using local urokinase delivery with the Dispatch catheter.

D. Waters, J. Dougherty, R. McKay, 1995, Catheterization and cardiovascular diagnosis.

1 GHz differential phase acoustic lens design for surface and subsurface applications

H. Bertoni, B. Khuri-Yakub, D. Waters, 1990, IEEE Symposium on Ultrasonics.

Differential phase acoustic microscope for micro-NDE

T. Pusateri, S. R. Huang, D. Waters, 1992 .

Atorvastatin Has a Dose‐Dependent Beneficial Effect on Kidney Function and Associated Cardiovascular Outcomes: Post Hoc Analysis of 6 Double‐Blind Randomized Controlled Trials

D. Waters, S. Bangalore, G. Hovingh, 2019, Journal of the American Heart Association.

Regression of Coronary Atherosclerosis

D. Waters, J. Lespérance, J. Lésperance, 2012, Drugs.

Relationship of High‐Density Lipoprotein Cholesterol With Renal Function in Patients Treated With Atorvastatin

P. Barter, D. Waters, D. Demicco, 2018, Journal of the American Heart Association.

When Diastole Lets You Down: Clinical Relevance of a Widened Pulse Pressure.

D. Waters, V. Bittner, Jordan Tannenbaum, 2019, The Canadian journal of cardiology.

Emerging Cardiovascular Disease Biomarkers and Incident Diabetes Mellitus Risk in Statin-Treated Patients With Coronary Artery Disease (from the Treating to New Targets [TNT] Study).

D. Waters, J. Kastelein, D. Demicco, 2016, The American journal of cardiology.

Symptomatic coronary artery spasm following radiotherapy for Hodgkin's disease.

D. Waters, D. Miller, V. Dangoisse, 1983, Chest.

Percutaneous mitral valvuloplasty in surgical high risk patients.

R. Petitclerc, D. Waters, T. Lefévre, 1991, Journal of the American College of Cardiology.

Treatment of recurrent restenosis with repeat percutaneous transluminal coronary angioplasty.

D. Waters, P. Joly, D. Palisaitis, 1988, The American journal of cardiology.

Multiple coronary angioplasty: a model to discriminate systemic and procedural factors related to restenosis.

D. Waters, J. Lespérance, M. Lambert, 1988, Journal of the American College of Cardiology.

Are qualitative features of coronary artery lesions useful in predicting progression

D. Waters, P. Théroux, G. Hudon, 1994 .

High-density lipoprotein, but not low-density lipoprotein cholesterol levels influence short-term prognosis after acute coronary syndrome: results from the MIRACL trial.

M. Ezekowitz, D. Waters, W. Sasiela, 2005, European heart journal.

Preoperative and Long‐term Cardiac Risk Assessment Predictive Value of 23 Clinical Descriptors, 7 Multivariate Scoring Systems, and Quantitative Dipyridamole Imaging in 360 Patients

D. Waters, J. Lette, M. Cerino, 1992, Annals of surgery.

Reactivation of unstable angina after the discontinuation of heparin.

D. Waters, P. Théroux, J. Mccans, 1992, The New England journal of medicine.

Unstable angina: special considerations in the postbypass patient.

D. Waters, P. Theroux, 1991, Cardiovascular clinics.

Previous coronary artery bypass grafting as an adverse prognostic factor in unstable angina pectoris.

D. Waters, P. Théroux, Denis Roy, 1986, The American journal of cardiology.

Previously Undiagnosed Variant Angina as a Cause of Chest Pain after Coronary Artery Bypass Surgery

D. Waters, P. Théroux, J. Crittin, 1980, Circulation.

Utility of biomarkers and imaging in the development of drugs for the treatment of coronary atherosclerosis.

D. Waters, 2012, The Canadian journal of cardiology.

The Myocardial Ischemia Reduction with Acute Cholesterol Lowering (MIRACL) trial: a new frontier for statins?

D. Waters, A. Olsson, G. Schwartz, 2001, Current controlled trials in cardiovascular medicine.

Mechanical or Metabolic Treatment for Coronary Disease: Synergistic, Not Antagonistic, Approaches

D. Waters, C. Gemayel, 2002, Cardiology in review.

Are we aggressive enough in lowering cholesterol?

D. Waters, 2001, The American journal of cardiology.

Should intensive cholesterol lowering play a role in the management of acute coronary syndromes?

D. Waters, R. Azar, 2000, The American journal of cardiology.

The Editor’s Roundtable: Statin Therapy in Acute Coronary Syndrome

W. Roberts, D. Waters, R. McPherson, 2007 .

Notes From Cardiology Clinic: Woman, Lost During Follow-up.

D. Waters, 2019, The Canadian journal of cardiology.

Papering over the cracks: meta-analysis to define the role of percutaneous coronary intervention in patients with stable angina.

D. Waters, 2013, The Canadian journal of cardiology.

Title Papering Over the Cracks : Meta-analysis to Define the Role of Percutaneous Coronary Intervention in Patients With Stable Angina Permalink

D. Waters, 2013 .

Search for neutral supersymmetric Higgs bosons in pp̄ collisions at √s = 1.8 TeV

M. Spiropulu, M. Albrow, D. Amidei, 2001 .

Diagnostic accuracy of exercise ECG lead systems in clinical subsets of women.

B. Chaitman, D. Waters, M. Bourassa, 1982, Circulation.

The SPARCL study: extending the indications of statin therapy for stroke?

D. Waters, D. D. Yeh, 2007, Nature Clinical Practice Cardiovascular Medicine.

Comparison of cardiac troponin I, creatine kinase-MB, and myoglobin for detection of acute ischemic myocardial injury in a swine model.

D. Waters, J. Fallon, A. Wu, 1998, American journal of clinical pathology.

Impact of acute propranolol administration on dobutamine-induced myocardial ischemia as evaluated by myocardial perfusion imaging and echocardiography.

D. Waters, G. Heller, L. Gillam, 1997, The American journal of cardiology.

Symptom-limited versus low level exercise testing before hospital discharge after myocardial infarction.

D. Waters, P. Théroux, M. Juneau, 1992, Journal of the American College of Cardiology.

Duration of abnormal SPECT myocardial perfusion imaging following resolution of acute ischemia: an angioplasty model.

D. Waters, E. Ficaro, G. Heller, 2003, Journal of the American College of Cardiology.

Pathophysiology of Acute Coronary Syndromes

D. Waters, A. Wu, S. Giri, 1998 .

Quantitative Angiographic Morphology of the Coronary Artery Lesions at Risk of Thrombotic Occlusion

D. Waters, P. Théroux, Y. Taeymans, 1992, Circulation.

1117-88 High-density lipoprotein, but not low-density lipoprotein cholesterol levels influence short-term prognosis after acute coronary syndrome: Results from the MIRACL trial

M. Ezekowitz, D. Waters, W. Sasiela, 2004 .

Clinical and angiographic factors associated with progression of coronary artery disease.

D. Waters, P. Finès, Y. Taeymans, 1984, Journal of the American College of Cardiology.

Novel Collagen Vascular Plug for Femoral Arteriotomy Sealing: Acute and Chronic In Vivo Studies

W. Quist, D. Waters, R. McKay, 1996 .

Patient Selection and Definition of Study Endpoints

D. Waters, P. Schulman, 1994 .

Clinical and angiographic features of coronary artery disease in young women

D. Waters, C. Halphen, P. David, 1978 .

Measurement of vector boson plus D∗ (2010)+ meson production in p-p collisions at s =1.96 TeV MEASUREMENT of VECTOR BOSON PLUS D∗ (2010)+ ... T. AALTONEN et al

D. Whiteson, T. Aaltonen, S. Amerio, 2016 .

Measurement of the production and differential cross sections of W[superscript +]W[superscript -] bosons in association with jets in p[bar over p] collisions at √s = 1.96 TeV

M. Dorigo, D. Whiteson, T. Aaltonen, 2015 .

Search for production of an Υ (1 S) meson in association with a W or Z boson using the full 1.96 TeV pp ¯ collision data set at CDF

D. Whiteson, T. Aaltonen, S. Amerio, 2015 .

Combination of measurements of the top-quark pair production cross section from the Tevatron Collider

D. Whiteson, T. Aaltonen, S. Amerio, 2013, 1309.7570.

Invariant-mass distribution of jet pairs produced in association with a W boson in p p ̄ collisions at s =1.96TeV using the full CDF Run II data set invariant-mass distribution of ⋯ T. Aaltonen et al.

D. Whiteson, T. Aaltonen, S. Amerio, 2014 .

Search for a dijet resonance in events with jets and missing transverse energy in pp¯ collisions at s√=1.96 TeV

D. Whiteson, T. Aaltonen, S. Amerio, 2013 .

Search for $B_s \rightarrow \mu^{+}\mu^{-}$ and $B_d \rightarrow \mu^{+}\mu^{-}$ decays with the full CDF Run II data set

Ji Eun Kim, D. Whiteson, T. Aaltonen, 2013 .

Transverse momentum cross section of e +e - pairs in the Z-boson region from pp̄ collisions at √s=1.96TeV

M. Dorigo, D. Whiteson, V. Ramakrishnan, 2012 .

Measurement of t(t)over-cap spin correlation in p(p)over-cap collisions using the CDF II detector at the Tevatron

M. Dorigo, D. Whiteson, V. Ramakrishnan, 2011 .

Search for the supersymmetric partner of the top quark in p(p)over-bar collisions at root s = 1.96 TeV

D. Whiteson, V. Ramakrishnan, M. Feindt, 2010 .

Search for High-Mass e(+) e(-) Resonances in p (p)over-bar Collisions at root s=1.96 TeV

Cavaliere, Krutelyov, Rekovic, 2009 .

Search for Gluino-Mediated Bottom Squark Production in p(p) over bar Collisions at root s=1.96 TeV RID G-1087-2011 RID E-4473-2011

Cavaliere, Krutelyov, Khotilovich, 2009 .

Study of the associated production of photons and b-quark jets in p(p)over-bar collisions at root s=1.96 TeV

D. Whiteson, V. Ramakrishnan, M. Feindt, 2010 .

Search for new physics in lepton plus photon plus X events with 929 pb(-1) of pp collisions at root s=1.96 TeV

Krutelyov, Rekovic, Khotilovich, 2007 .

Measurement of mass and width of the excited charmed meson states D10 and D2*0 at CDF

D. Whiteson, M. Feindt, J. Adelman, 2006 .

Measurement of the b jet cross section in events with a Z boson in pp(-) collisions at root s 1. 96 TeV

D. Whiteson, M. Feindt, J. Adelman, 2006 .

Searches for new physics in events with a photon and b-quark jet at CDF

M. Spiropulu, M. Albrow, D. Amidei, 2002 .

Search for second-generation scalar leptoquarks in p(p)over-bar collisions at root s=1.96 TeV

Krutelyov, Rekovic, Khotilovich, 2005 .

Measurement of the inclusive jet cross section using the k(T) algorithm in p(p)over-bar collisions at root s=1.96 TeV with the CDF II detector

Krutelyov, Rekovic, Khotilovich, 2007 .

Effects of nitroglycerin at therapeutic doses on platelet aggregation in unstable angina pectoris and acute myocardial infarction.

D. Waters, P. Théroux, J. Diodati, 1990, The American journal of cardiology.

Ventricular arrhythmias during ergonovine-induced episodes of variant angina.

D. Waters, D. Miller, P. Théroux, 1984, American heart journal.

Sudden death in two patients with variant angina and apparently minimal fixed coronary stenoses.

D. Waters, M. Bourassa, P. Puddu, 1983, Journal of electrocardiology.

Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: A randomized control trial

J. Hsia, M. Proschan, D. Gordon, 2003 .

Prognostic role of troponin T versus troponin I in unstable angina pectoris for cardiac events with meta-analysis comparing published studies.

D. Waters, A. Wu, Y. J. Feng, 1998, The American journal of cardiology.

Care of the patient with previous coronary bypass surgery.

D. Waters, M. Bourassa, L. K. Smith, 1991, Cardiovascular clinics.

Progression of Coronary Atherosclerosis

D. Waters, R. Havel, G. Gosselin, 2005 .

Platelet aggregation, coronary artery disease progression and future coronary events.

D. Waters, J. Lam, J. Latour, 1994, The American journal of cardiology.

Ezetimibe alone reduces low-density lipoprotein cholesterol in HIV-infected patients receiving combination antiretroviral therapy.

D. Waters, J. Eron, D. Wohl, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Search for large extra dimensions in the production of jets and missing transverse energy in pp̄ collisions at s=1.96TeV

D. Whiteson, M. Feindt, J. Adelman, 2006 .

Effect of low-grade conductive heating on vascular compliance during in vitro balloon angioplasty.

D. Waters, L. Gillam, R. McKay, 1994, American heart journal.

Effects of cigarette smoking on the angiographic evolution of coronary atherosclerosis. A Canadian Coronary Atherosclerosis Intervention Trial (CCAIT) Substudy. CCAIT Study Group.

D. Waters, L. Higginson, P. Gladstone, 1996, Circulation.

Intensive lipid-lowering with atorvastatin for secondary prevention in patients after coronary artery bypass surgery.

Sanjiv J. Shah, P. Barter, D. Waters, 2008, Journal of the American College of Cardiology.

Proischemic complications of dihydropyridine calcium channel blockers.

D. Waters, 1991, Circulation.

Women's Ischemic Syndrome Evaluation: current status and future research directions: report of the National Heart, Lung and Blood Institute workshop: October 2-4, 2002 : Section 4: lessons from hormone replacement trials.

R. Langer, J. Hsia, D. Gordon, 2004, Circulation.

Chlamydia Pneumoniae and Atherosclerosis: From Koch Postulates to Clinical Trials

D. Waters, Catherine Liu, 2005, Progress in Cardiovascular Diseases.

Acute pulmonary edema caused by prolonged myocardial stunning after dipyridamole-thallium imaging.

D. Waters, J. Lette, A. Gagnon, 1989, The American journal of medicine.

Combined assessment of myocardial perfusion and left ventricular function with exercise technetium-99m sestamibi gated single-photon emission computed tomography can differentiate between ischemic and nonischemic dilated cardiomyopathy.

M. G. Levine, J. Clive, P. Danias, 1998, The American journal of cardiology.

Recent advances in drug therapy for coronary artery disease.

D. Waters, 1985, Canadian Medical Association journal.

A randomized study comparing propranolol and diltiazem in the treatment of unstable angina.

D. Waters, P. Théroux, Y. Taeymans, 1985, Journal of the American College of Cardiology.

Action of nifedipine in ischemic heart disease.

D. Waters, D. Miller, P. Théroux, 1983, Canadian family physician Medecin de famille canadien.

Spontaneous remission is a frequent outcome of variant angina.

D. Waters, P. Théroux, A. Bouchard, 1983, Journal of the American College of Cardiology.

Comparative Sensitivity of Exercise, Cold Pressor and Ergonovine Testing in Provoking Attacks of Variant Angina in Patients with Active Disease

D. Waters, D. Miller, P. Théroux, 1982, Circulation.

Provocative testing with ergonovine to assess the efficacy of treatment with nifedipine, diltiazem and verapamil in variant angina.

D. Waters, P. Théroux, J. Szlachcic, 1981, The American journal of cardiology.

Ergonovine testing to detect spontaneous remissions of variant angina during long-term treatment with calcium antagonist drugs.

D. Waters, P. Théroux, J. Szlachcic, 1981, The American journal of cardiology.

S-T segment elevation and coronary spasm in response to exercise.

B. Chaitman, D. Waters, P. Théroux, 1981, The American journal of cardiology.

Cost-effectiveness of low-dose colchicine after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)

R. Diaz, J. Tardif, D. Waters, 2020, European heart journal. Quality of care & clinical outcomes.

Management strategies in unstable coronary artery disease—Current problems and future directions

J. Cleland, D. Waters, A. Maseri, 1999, Clinical cardiology.

Effects of estrogen replacement with and without medroxyprogesterone acetate on brachial flow-mediated vasodilator responses in postmenopausal women with coronary artery disease.

D. Reboussin, D. Waters, J. Yeboah, 2007, American heart journal.

Relation of C-reactive protein to extent and severity of coronary narrowing in patients with stable angina pectoris or abnormal exercise tests.

D. Waters, A. Wu, F. Kiernan, 2000, The American journal of cardiology.

Risk of new-onset diabetes and cardiovascular risk reduction from high-dose statin therapy in pre-diabetics and non-pre-diabetics: an analysis from TNT and IDEAL.

D. Waters, J. Kastelein, D. Demicco, 2015, Journal of the American College of Cardiology.

Hemodynamics and coronary flow following diltiazem administration in anesthetized dogs and in humans.

D. Waters, M. Bourassa, P. Théroux, 1980, Chest.

Provocative Testing with Ergonovine to Evaluate the Efficacy of Treatment with Calcium Antagonists in Variant Angina

D. Waters, P. Théroux, J. Crittin, 1979, Circulation.

Coronary angiographic significance of left anterior fascicular block during acute myocardial infarction.

D. Waters, X. Bosch, D. Roy, 1985, Journal of the American College of Cardiology.

The inflammatory etiology of unstable angina.

D. Waters, R. Azar, 1996, American heart journal.

The history of the coronary care unit.

E. Rapaport, D. Waters, K. Khush, 2005, The Canadian journal of cardiology.

Predictors of new-onset diabetes in patients treated with atorvastatin: results from 3 large randomized clinical trials.

P. Barter, D. Waters, J. Kastelein, 2011, Journal of the American College of Cardiology.

Search for Z??e+e- Using Dielectron Mass and Angular Distribution

D. Whiteson, M. Feindt, J. Adelman, 2006 .

Erratum: Search for Bs0→μ+μ- and B0→μ+μ- decays with CDF II (Physical Review Letters (2011) 107 (191801))

M. Dorigo, D. Whiteson, V. Ramakrishnan, 2011 .

Randomized double-blind comparison of two doses of Hirulog with heparin as adjunctive therapy to streptokinase to promote early patency of the infarct-related artery in acute myocardial infarction.

D. Waters, P. Théroux, F. Pérez-Villa, 1995, Circulation.

Prognostic value of cardiac troponin I in patients with chest pain.

D. Waters, A. Wu, J. Contois, 1996, Clinical chemistry.

Effect of a standardized meal on the threshold of exercise-induced myocardial ischemia in patients with stable angina.

D. Waters, A. Desideri, J. Grégoire, 1993, Journal of the American College of Cardiology.

Exercise Testing in Patients with Variant Angina: Results, Correlation with Clinical and Angiographic Features and Prognostic Significance

D. Waters, M. Bourassa, J. Szlachcic, 1982, Circulation.

Circadian patterns in coronary disease: the mournfulness of morning.

D. Waters, P. Bogaty, 1988, The Canadian journal of cardiology.

Functional assessment with electrocardiographic gated single-photon emission computed tomography improves the ability of technetium-99m sestamibi myocardial perfusion imaging to predict myocardial viability in patients undergoing revascularization.

M. G. Levine, D. Waters, G. Heller, 1999, The American journal of cardiology.

Notes From Cardiology Clinic: When Our Responsibilities Extend Beyond the Patient.

D. Waters, 2019, The Canadian journal of cardiology.

Comparative antianginal effects of nisoldipine and nifedipine in patients with chronic stable angina.

B. Chaitman, D. Waters, J. Lam, 1987, American heart journal.

Serial exercise testing in patients with effort angina: variable tolerance, fixed threshold.

D. Waters, J. Mccans, P. Crean, 1985, Journal of the American College of Cardiology.

Left main coronary artery stenosis in young patients.

D. Waters, P. Théroux, J. Crittin, 1979, Chest.

Abciximab in primary coronary angioplasty for acute myocardial infarction improves short- and medium-term outcomes.

Paul D. Thompson, P. Thompson, D. Waters, 1998, Journal of the American College of Cardiology.

Primary angioplasty using a urokinase-coated hydrogel balloon in acute myocardial infarction during pregnancy.

D. Waters, J. Dougherty, J. Hirst, 1995, Catheterization and cardiovascular diagnosis.

Direct comparison of arbutamine and dobutamine stress testing with myocardial perfusion imaging and echocardiography in patients with coronary artery disease.

D. Waters, G. Heller, L. Gillam, 1997, The American journal of cardiology.

Postscripts from the Post-Coronary Artery Bypass Graft trial: the sustained benefit of more aggressive cholesterol lowering and the enigma of low-dose anticoagulation.

D. Waters, R. Azar, 2000, Circulation.

Myocardial cell death and apoptosis in hibernating myocardium.

D. Waters, J. Fallon, L. Gillam, 1997, Journal of the American College of Cardiology.

Time to Recognize HIV Infection as a Major Cardiovascular Risk Factor

D. Waters, P. Hsue, 2018, Circulation.

Hormone therapy and antioxidant vitamins do not improve endothelial vasodilator function in postmenopausal women with established coronary artery disease: a substudy of the Women's Angiographic Vitamin and Estrogen (WAVE) trial.

B. Howard, D. Waters, F. Cobb, 2005, Atherosclerosis.

‘Second Generation’ Dihydropyridine Calcium Antagonists

D. Waters, D. Freedman, D. Waters, 1987, Drugs.

Hospital treatment of congestive heart failure. Management according to hemodynamic profile.

D. Waters, J. Forrester, 1978, The American journal of medicine.

Chronic oral vasodilator therapy to control heart failure in postinfarction ventricular septal defect.

D. Waters, G. Pelletier, D. Phaneuf, 1979, Catheterization and cardiovascular diagnosis.

Endothelium-derived nitric oxide attenuates neutrophil adhesion to endothelium under arterial flow conditions.

D. Waters, P. Provost, L. Lacoste, 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

Fibrinopeptide A: A ubiquitous marker

D. Waters, J. Lam, 1989 .

Is thrombolytic therapy striking out in unstable angina?

D. Waters, J. Lam, 1992, Circulation.

The past and future of heart institutes: having moved beyond the one-trick pony.

D. Waters, 2014, The Canadian journal of cardiology.

HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials

Tom R. Gaunt, Aroon D. Hingorani, J. Gallacher, 2015, The Lancet.

Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction.

R. Diaz, J. López-Sendón, J. Tardif, 2019, The New England journal of medicine.

Left ventricular remodeling in myocardial hibernation.

D. Waters, L. Gillam, T. Lai, 1997, Circulation.

The Prehospital Discharge Evaluation of the Patient with Acute Myocardial Infarction

D. Waters, 1985 .

Effect of torcetrapib on glucose, insulin, and hemoglobin A1c in subjects in the Investigation of Lipid Level Management to Understand its Impact in Atherosclerotic Events (ILLUMINATE) trial.

P. Barter, J. Kastelein, J. Tardif, 2011, Circulation.

Whither the coronary care unit?

D. Waters, P. Théroux, 1987, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

Massive mitral regurgitation caused by tearing of the anterior leaflet during percutaneous mitral balloon valvuloplasty.

D. Waters, Á. Cequier, I. Dyrda, 1988, The American journal of medicine.

Measurement of W-boson polarization in top-quark decay using the full CDF Run II data set

D. Whiteson, T. Aaltonen, S. Amerio, 2013 .

Search for new physics in photon-lepton events in p(p)over-bar collisions at root s=1.8 TeV

M. Spiropulu, M. Albrow, D. Amidei, 2002 .

Measurements of branching fraction ratios and CP asymmetries in B(+/-) -> DCPK(+/-) decays in hadron collisions RID G-1087-2011 RID E-4473-2011

Cavaliere, Krutelyov, Khotilovich, 2010 .

Improving Statin Noncompliance: If You Build It, Will They Come?

D. Waters, J. Udell, L. Ferreira-Legere, 2019, The Canadian journal of cardiology.

Do statins confer early benefit after acute coronary syndromes? The results from FLORIDA.

D. Waters, P. Varosy, 2002, European heart journal.

Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis.

Paul Welsh, Jennifer E Ho, Christopher P Cannon, 2011, JAMA.

Body-Weight Fluctuations and Outcomes in Coronary Disease.

D. Waters, S. Bangalore, F. Messerli, 2017, The New England journal of medicine.

Measurement of σχc2B(χc2→J/ψγ)/ σχc1B(χc1→J/ψγ) in pp̄ Collisions at s=1.96TeV

D. Whiteson, M. Feindt, J. Adelman, 2007 .

Measurement of R=B(t→Wb)/B(t→Wq) in top-quark-pair decays using lepton+jets events and the full CDF run II dataset

D. Whiteson, T. Aaltonen, S. Amerio, 2013 .

Divergent effect of dopamine upon ischemic myocardium with partial and total coronary occlusion

D. Waters, J. Forrester, H. Swan, 1976 .

Search for long-lived charged massive particles in p p̄ collisions at √s = 1.8 TeV

M. Spiropulu, M. Albrow, D. Amidei, 2003 .

Hemodynamic, platelet and clinical responses to prostacyclin in unstable angina pectoris.

D. Waters, P. Théroux, J. Diodati, 1990, The American journal of cardiology.

Thrombolytic therapy for myocardial infarction: the problem, the promise and the price.

D. Waters, A. Wiseman, 1988, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

Notes from Cardiology Clinic: You Can't Ride with the Cops, But Cheer for the Robbers.

D. Waters, 2021, The Canadian journal of cardiology.

Lipid Abnormalities in Persons Living With HIV Infection.

D. Waters, P. Hsue, 2019, The Canadian journal of cardiology.

Pravachol decreases platelet thrombus formation in hypercholesterolaemic coronary patients in conjunction with improvement in serum lipids

D. Waters, J. Hung, J. Lam, 1994 .

Impact of high-dose atorvastatin therapy and clinical risk factors on incident aortic valve stenosis in patients with cardiovascular disease (from TNT, IDEAL, and SPARCL).

P. Barter, J. Tardif, D. Waters, 2014, The American journal of cardiology.

Prognostic Value of Limited Exercise Testing before Hospital Discharge Following Myocardial Infarction

D. Waters, P. Théroux, 1981 .

Study design of Dal-GenE, a pharmacogenetic trial targeting reduction of cardiovascular events with dalcetrapib.

M. Pfeffer, J. McMurray, H. White, 2020, American heart journal.

Colchicine for community-treated patients with COVID-19 (COLCORONA): a phase 3, randomised, double-blinded, adaptive, placebo-controlled, multicentre trial

D. Gaudet, S. Lévesque, J. Tardif, 2021, The Lancet Respiratory Medicine.

The curse of target lesion calcification: still active after all these years.

D. Waters, R. Azar, 2014, Journal of the American College of Cardiology.

Prognostic value of cardiac troponin T in unstable angina pectoris.

D. Waters, A. Wu, R. McKay, 1995, The American journal of cardiology.

Ergonovine testing in a coronary care unit.

D. Waters, J. Szlachcic, R. Bonan, 1980, The American journal of cardiology.

Newer concepts in the treatment of unstable angina pectoris.

D. Waters, J. Lam, P. Theroux, 1991, The American journal of cardiology.

Efficacy of Colchicine in Non-Hospitalized Patients with COVID-19

D. Gaudet, S. Lévesque, J. Tardif, 2021, medRxiv.

A randomized placebo-controlled trial to assess the efficacy of antiinflammatory therapy with methylprednisolone in unstable angina (MUNA trial).

P. Stone, D. Waters, A. Wu, 2000, European heart journal.

Are Cholesterol Treatment Targets a Deterrent to Optimal Lipid-Lowering Therapy?

D. Waters, 2017, JAMA cardiology.

PCSK9 Inhibitors for Statin Intolerance?

D. Waters, S. Bangalore, P. Hsue, 2016, JAMA.

Reply: To PMID 23219296.

D. Waters, S. Boekholdt, Terje R. Pedersen, 2013, Journal of the American College of Cardiology.

Long-term prognosis after myocardial infarction in patients with previous coronary artery bypass surgery.

D. Waters, P. Théroux, D. Roy, 1988, Journal of the American College of Cardiology.

Early postinfarction ischemia: clinical, angiographic, and prognostic significance.

D. Waters, P. Théroux, X. Bosch, 1987, Circulation.

Notes From Cardiology Clinic: Health Care Heroine, Unpaid and Unappreciated.

D. Waters, 2020, The Canadian journal of cardiology.

Efficacy of high dose intravenous heparin for treatment of left ventricular thrombi with high embolic risk.

D. Waters, C. Hamm, W. Bleifeld, 1994, Journal of the American College of Cardiology.

Reply: statin-induced low low-density lipoprotein cholesterol level: is lower better?

S. Grundy, D. Waters, J. Kastelein, 2015, Journal of the American College of Cardiology.

Measurement of σΛb0/ σB̄0×B(Λb0→Λc+π-)/B(B̄0→D+π- ) in pp̄ Collisions at s=1.96TeV

D. Whiteson, M. Feindt, J. Adelman, 2007 .

Comment Proischemic Complications of Dihydropyridine Calcium Channel Blockers

D. Waters, 2005 .

Effect of diltiazem slow-release formulation on silent myocardial ischemia in stable coronary artery disease. The Canadian Multicenter Diltiazem Study Group.

D. Waters, M. Juneau, P. Theroux, 1992, The American journal of cardiology.

Usefulness of serum endothelin levels in predicting death and myocardial infarction but not coronary progression in postmenopausal women with coronary disease (from the Women's Angiographic Vitamin and Estrogen [WAVE] study).

D. Waters, P. Ouyang, P. Hsue, 2005, The American journal of cardiology.

Refractory variant angina controlled with combined drug therapy in a patient with a single coronary artery.

D. Waters, G. Pelletier, D. Phaneuf, 1980, Catheterization and cardiovascular diagnosis.

Looking for coronary disease in patients with atrial fibrillation.

D. Waters, P. Kohli, 2014, The Canadian journal of cardiology.

Statins before stents: does an ounce of prevention improve outcomes?

D. Waters, Paul Frey, 2010, The Canadian journal of cardiology.

Measurement of the cross section for prompt diphoton production in pp Collisions at TeV

M. Spiropulu, M. Feindt, J. Adelman, 2005 .

Measurement of the t(t)over-bar production cross section in p(p)over-bar collisions at root s=1.96 TeV using lepton plus jets events with secondary vertex b-tagging

Krutelyov, Rekovic, Khotilovich, 2005 .

The underlying event in hard interactions at the Tevatron $\bar p p$ collider

M. Spiropulu, M. Albrow, D. Amidei, 2004 .

Measurement of the B-cmeson lifetime in the decay B-c→J/ψπ⁻

M. Dorigo, D. Whiteson, V. Ramakrishnan, 2013 .

Search for neutral Higgs bosons in events with multiple bottom quarks at the Tevatron

R. K. Shivpuri, M. Dorigo, D. Whiteson, 2012 .

Erratum: Measurement of the inclusive jet cross section at the Fermilab Tevatronpp¯collider using a cone-based jet algorithm [Phys. Rev. D78, 052006 (2008)]

D. Whiteson, V. Ramakrishnan, M. Feindt, 2009 .

Erratum: Measurement of the inclusive jet cross section using the kT algorithm in pp̄ collisions at s=1.96TeV with the CDF II detector (Physical Review D - Particles, Fields, Gravitation and Cosmology (2007) 75, (092006))

D. Whiteson, M. Feindt, J. Adelman, 2007 .

Measurement of the Inclusive Jet Cross Section using the {\boldmath $k_{\rm T}$} algorithmin{\boldmath $p\overline{p}$} Collisions at{\boldmath $\sqrt{s}$} = 1.96 TeV with the CDF II Detector

J. P. Fernández, Shapiro, Neubauer, 2007 .

Erratum: Indirect measurement of sin -2θW (MW) using e+e - pairs in the Z-boson region with pp̄ collisions at a center-of-momentum energy of 1.96 TeV (Physical Review D (2013) 88 (072002))

M. Dorigo, D. Whiteson, T. Aaltonen, 2013 .

Search for Bs0→μ+μ- and B0→μ+μ- decays in pp collisions at √s=7TeV

M. Spiropulu, M. Feindt, T. Akimoto, 2011 .

Search for WW and WZ resonances decaying to electron, missing ET, and two jets in pp̄ collisions at √s=1.96TeV.

Damon A. Clark, D. Whiteson, V. Ramakrishnan, 2010 .

The DUNE Far Detector Interim Design Report Volume 1: Physics, Technology and Strategies

D. P. Méndez, J. I. Crespo-Anad'on, V. P. Luzio, 2018 .

Deep Underground Neutrino Experiment (DUNE) Near Detector Conceptual Design Report

J. I. Crespo-Anad'on, V. P. Luzio, P. Baldi, 2021, Instruments.

Volume III. DUNE far detector technical coordination

Jorge S. Díaz, V. P. Luzio, J. I. Crespo-Anadón, 2020, Journal of Instrumentation.

Deep Underground Neutrino Experiment (DUNE), Far Detector Technical Design Report, Volume III DUNE Far Detector Technical Coordination

V. P. Luzio, J. I. Crespo-Anadón, P. Baldi, 2020, 2002.03008.

Measurement of the W Boson Mass with the Collider Detector at Fermilab

Hee Chan Kim, M. Spiropulu, M. Albrow, 1998, hep-ex/0007044.

Search for the Rare Radiative Decay: $W\rightarrow\pi\gamma$ in $p\bar{p}$ Collisions at $\sqrt{s} = 1.96$ TeV

Neubauer, M. Dorigo, D. Whiteson, 2011 .

Limits on anomalous triple gauge couplings in p(p)over-bar collisions at root s=1.96 TeV

Krutelyov, Rekovic, Khotilovich, 2007 .

Measurement of the Λb0 lifetime in Λb0→Λc+π - decays in pp̄ collisions at √s=1.96TeV

D. Whiteson, V. Ramakrishnan, M. Feindt, 2010 .

Search for Λb0→pπ and Λb0→pK decays in pp̄ collisions at s=1.96 TeV

G. P. Yeh, D. Whiteson, M. Feindt, 2005 .

Measurement of the two-jet differential cross section in p{bar p} collisions at

M. Spiropulu, M. Albrow, D. Amidei, 2001 .

Search for anomalous production of diphoton events with missing transverse energy at CDF and limits on gauge-mediated supersymmetry-breaking models

M. Spiropulu, M. Feindt, J. Adelman, 2005 .

Evidence for the exclusive decay Bc±→J/ψπ± and measurement of the mass of the Bc± meson

D. Whiteson, M. Feindt, J. Adelman, 2006 .

Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial.

M. Ezekowitz, B. Chaitman, D. Waters, 2001, JAMA.

Pathophysiology of Unstable Angina Pectoris: Clinical, Angiographic and Therapeutic Observations

D. Waters, P. Théroux, Y. Taeymans, 1988 .

Clinical characteristics of patients with variant angina complicated by myocardial infarction or death within 1 month.

D. Waters, D. Miller, P. Théroux, 1982, The American journal of cardiology.

Atorvastatin for acute coronary syndromes.

M. Ezekowitz, B. Chaitman, D. Waters, 2001, JAMA.

Local delivery of heparin to balloon angioplasty sites with a new angiotherapy catheter: pharmacokinetics and effect on platelet deposition in the porcine model.

D. Waters, R. McKay, M. Azrin, 1997, Catheterization and cardiovascular diagnosis.

Percentage change rather than plasma level of LDL-cholesterol determines therapeutic response in coronary heart disease.

D. Waters, G. Thompson, J. Hollyer, 1995, Current opinion in lipidology.

Very low levels of atherogenic lipoproteins and the risk for cardiovascular events: a meta-analysis of statin trials.

P. Ridker, G. Hitman, A. Gotto, 2014, Journal of the American College of Cardiology.

Recurrence of Prinzmetal angina seven years following aortocoronary bypass surgery: a clinical and angiographic follow-up.

D. Waters, J. Crittin, J. Lésperance, 1979, Catheterization and cardiovascular diagnosis.

Reduction of low-density lipoprotein cholesterol in patients with coronary heart disease and metabolic syndrome: analysis of the Treating to New Targets study

S. Grundy, P. Barter, D. Waters, 2006, The Lancet.

Taking Hockey to Heart: Potential Coronary Risks of Watching Exciting Games.

S. Nattel, D. Waters, 2017, The Canadian journal of cardiology.

Interventions that beneficially influence the evolution of coronary atherosclerosis. The case for calcium channel blockers.

D. Waters, J. Lésperance, 1992, Circulation.

Search for resonant production of tt[over ¯] decaying to jets in pp[over ¯] collisions at sqrt[s]=1.96 TeV

M. Dorigo, D. Whiteson, V. Ramakrishnan, 2011 .

Measurement of the helicity fractions of W bosons from top quark decays using fully reconstructed tt events with CDF II

D. Whiteson, M. Feindt, J. Adelman, 2007 .

Electroweak Precision Measurements and Direct Higgs Searches at the Tevatron

D. Waters, 2012 .

Measurements of branching fraction ratios and CP-asymmetries in suppressed B[superscript -]→D(→K[superscript +]π[superscript -])K[superscript -] and B[superscript -]→D(→K[superscript +]π[superscript -])π[superscript -] decays

M. Dorigo, D. Whiteson, V. Ramakrishnan, 2011 .

Editorial Looking for Coronary Disease in Patients With Atrial Fibrillation

D. Waters, P. Kohli, 2014 .

Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II).

Deborah Grady, Eric Vittinghoff, Steven Khan, 2002, JAMA.

Effects of Atorvastatin on Stroke in Patients With Unstable Angina or Non-Q-Wave Myocardial Infarction: A Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Substudy

M. Ezekowitz, B. Chaitman, D. Waters, 2002, Circulation.

Search for Second and Third Generation Leptoquarks Including Production via Technicolor Interactions in pp̅ Collisions at √s = 1.8 TeV

M. Spiropulu, M. Albrow, D. Amidei, 2000 .

Search for Long-Lived Massive Charged Particles in 1.96 TeV p(p)over-bar Collisions RID G-1087-2011 RID E-4473-2011

Cavaliere, Krutelyov, Khotilovich, 2009 .

VITAMIN D LEVELS ARE NOT RELATED TO MYALGIAS IN STATIN-TREATED PATIENTS WITH STABLE CORONARY DISEASE

D. Waters, N. Wenger, D. Demicco, 2010 .

Measurement of [Formula Presented] for high mass Drell-Yan [Formula Presented] pairs from [Formula Presented] collisions at [Formula Presented] TeV

M. Spiropulu, M. Albrow, D. Amidei, 2001 .

Heart failure in persons living with HIV infection

D. Waters, P. Hsue, 2017, Current opinion in HIV and AIDS.

PATHOPHYSIOLOGY OF HEART FAILURE IN PERSONS LIVING WITH HIV RECEIVING ANTIRETROVIRAL THERAPY

D. Waters, P. Hsue, 2017 .

significance Early postinfarction ischemia: clinical, angiographic, and prognostic

D. Waters, X. Bosch, D. Roy, 2011 .

Modern management of the CAD patient: aggressive lipid lowering

D. Waters, R. Azar, 2000 .

Acute coronary syndromes: is a unified management strategy emerging?

D. Waters, 1998, Journal of the American College of Cardiology.

Coronary Artery Spasm During Exercise in Patients with Variant Angina

B. Chaitman, D. Waters, G. Dupras, 1979, Circulation.

Measurement of the Top Quark Mass with the Collider Detector at Fermilab

M. Spiropulu, M. Albrow, D. Amidei, 1998, hep-ex/9810029.

Detection of myocardial ischemia.

D. Waters, J. Forrester, H. Swan, 1977, Cardiovascular clinics.

Measurements of bottom-antibottom azimuthal production correlations in proton-antiproton collisions at s=1.8TeV

M. Spiropulu, M. Albrow, D. Amidei, 2005 .

Abstract 2287: Diastolic Dysfunction is Common in Asymptomatic HIV Patients

Jeffrey N. Martin, A. Bolger, D. Waters, 2007 .

Smooth Muscle Cell Proliferation After Intramural Heparin Delivery

D. Waters, L. Bow, J. Barry, 2005 .

Is dipyridamole-thallium imaging preferable to submaximal exercise thallium testing for risk stratification after thrombolysis?

D. Waters, J. Lette, M. Cerino, 1990, American heart journal.

Measurement of the D⁺ -Meson Production Cross Section at Low Transverse Momentum in Pp¯ Collisions at √s =1.96 TeV

D. Whiteson, T. Aaltonen, S. Amerio, 2017 .

'Second generation' dihydropyridine calcium antagonists. Greater vascular selectivity and some unique applications.

D. Waters, D. Freedman, Donna D. Freedman, 1987, Drugs.

Lipids, inflammation, and chronic kidney disease: a SHARP perspective.

D. Waters, L. Vogt, 2018, Kidney international.

Search for single top quark production in p(p)over-bar collisions at root s=1.96 TeV in the missing transverse energy plus jets topology

D. Whiteson, V. Ramakrishnan, M. Feindt, 2010 .

737–4 Serum Cardiac Troponln T Measurements in Unstable Angina: An Early, Accurate Marker of Increased Risk

D. Waters, A. Wu, L. Pearsall, 1995 .

The Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Trial: Effects of Intensive Atorvastatin Treatment on Early Recurrent Events After an Acute Coronary Syndrome

M. Ezekowitz, B. Chaitman, D. Waters, 2000 .

Diffractive W and Z production at the Fermilab Tevatron

Hee Chan Kim, D. Whiteson, V. Ramakrishnan, 2010 .

THE EFFECT OF APO E GENOTYPE ON THE LIPID RESPONSE TO EXERCISE TRAINING

P. Thompson, D. Waters, J. Zmuda, 1999 .

Pathophysiology and initial management of the acute coronary syndromes.

D. Waters, S. Giri, 1996, Current opinion in cardiology.

ACORNE : Acoustic COsmic Ray Neutrino Experiment

D. Waters, L. Thompson, T. Sloan, 2022 .

Erratum: Measurement of particle production and inclusive differential cross sections in pp̄ collisions at √s=1.96TeV (Physical Review D - Particles, Fields, Gravitation and Cosmology)

G. P. Yeh, D. Whiteson, V. Ramakrishnan, 2010 .

First measurement of the ratio of branching fractions B(Λ0b→Λ+cμ−ν¯μ)/B(Λ0b→Λ+cπ−)

Cavaliere, Krutelyov, Khotilovich, 2009 .

Long-term prognosis of patients with variant angina.

D. Waters, D. Miller, P. Théroux, 1987, Circulation.

Calculation of high energy neutrino-nucleon cross sections and uncertainties using the Martin-Stirling-Thorne-Watt parton distribution functions and implications for future experiments

D. Waters, A. Connolly, R. Thorne, 2011, 1102.0691.

A Direct Top-Quark Width Measurement from Lepton + Jets Events at CDF II

D. Whiteson, V. Ramakrishnan, M. Feindt, 2010 .

Plasma triglycerides and cardiovascular events in the Treating to New Targets and Incremental Decrease in End-Points through Aggressive Lipid Lowering trials of statins in patients with coronary artery disease.

S. Grundy, D. Waters, O. Faergeman, 2009, The American journal of cardiology.

Prognostic value of exercise testing soon after myocardial infarction.

D. Waters, P. Théroux, C. Halphen, 1979, The New England journal of medicine.

Deep Underground Neutrino Experiment (DUNE), Far Detector Technical Design Report, Volume II: DUNE Physics

V. P. Luzio, J. I. Crespo-Anadón, P. Baldi, 2020, 2002.03005.

Effect of ACAT inhibition on the progression of coronary atherosclerosis.

Carl J Pepine, Paul Schoenhagen, E. Michelson, 2006, The New England journal of medicine.

Chapter 48 – Treatment of Cardiovascular Manifestations of HIV

D. Waters, P. Hsue, 2007 .

What a Cardiologist Needs to Know About Patients With Human Immunodeficiency Virus Infection

D. Waters, P. Hsue, 2005, Circulation.

Cholesterol Lowering Guidelines: From Whence We Came and Where We Are Now.

D. Waters, 2019, The Canadian journal of cardiology.

An Evidence-Based Guide to Cholesterol-Lowering Guidelines.

D. Waters, S. Boekholdt, D. Waters, 2017, The Canadian journal of cardiology.

Cardiovascular event reduction versus new-onset diabetes during atorvastatin therapy: effect of baseline risk factors for diabetes.

J. Kastelein, D. Waters, J. Kastelein, 2012, Journal of the American College of Cardiology.

Intensive lipid lowering with atorvastatin in patients with stable coronary disease.

Philip J. Barter, Heiner Greten, A. Gotto, 2005, The New England journal of medicine.

Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes. The MIRACL study.

Michael F. Oliver, Anders G. Olsson, Michael D. Ezekowitz, 2001, Indian heart journal.

A comparison of non-HDL and LDL cholesterol goal attainment in a large, multinational patient population: the Lipid Treatment Assessment Project 2.

D. Waters, J. Jukema, J. Ferrières, 2009, Atherosclerosis.

HIV infection and coronary heart disease: mechanisms and management

D. Waters, P. Hsue, 2019, Nature Reviews Cardiology.

Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease

D. Sparks, H. Feldman, M. Kivipelto, 2010, Neurology.

Coronary artery disease in young women: clinical and angiographic features and correlation with risk factors.

D. Waters, P. Théroux, C. Halphen, 1978, The American journal of cardiology.

Diltiazem at reperfusion reduces neutrophil accumulation and infarct size in dogs with ischaemic myocardium.

S. Nattel, D. Waters, G. Rousseau, 1991, Cardiovascular research.

Is variant angina the coronary manifestation of a generalized vasospastic disorder?

D. Waters, D. Miller, P. Théroux, 1981, The New England journal of medicine.

High plasma FGF21 levels predicts major cardiovascular events in patients treated with atorvastatin (from the Treating to New Targets [TNT] Study).

A. Keech, P. Barter, D. Waters, 2019, Metabolism: clinical and experimental.

Clinical and angiographic features and prognostic significance of early postinfarction angina with and without electrocardiographic signs of transient ischemia.

D. Waters, G. Sanz, P. Théroux, 1991, The American journal of medicine.

Will Colchicine Soon Be Part of Primary and Secondary Cardiovascular Prevention?

D. Waters, M. Samuel, 2020, The Canadian journal of cardiology.

A controlled clinical trial to assess the effect of a calcium channel blocker on the progression of coronary atherosclerosis.

P Théroux, D. Waters, R. Havel, 1990, Circulation.

Hyperlipidemia and coronary disease. Correction of the increased thrombogenic potential with cholesterol reduction.

D. Waters, J. Hung, L. Lacoste, 1995, Circulation.

Rationale and design of the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) study that evaluates atorvastatin in unstable angina pectoris and in non-Q-wave acute myocardial infarction.

M. Ezekowitz, B. Chaitman, D. Waters, 1998, The American journal of cardiology.

Statin-centric versus low-density lipoprotein-centric approach for atherosclerotic cardiovascular disease prevention: a Singapore perspective.

D. Waters, C. F. Liew, J. Choo, 2016, Singapore medical journal.

Exploring new indications for statins beyond atherosclerosis: Successes and setbacks.

D. Waters, 2010, Journal of cardiology.

Role of Adenylate Cyclase 9 in the Pharmacogenomic Response to Dalcetrapib

M. Pfeffer, F. Sacks, J. Tardif, 2021, Circulation. Genomic and precision medicine.

Comparison of clinical variables and variables derived from a limited predischarge exercise test as predictors of early and late mortality after myocardial infarction.

D. Waters, P. Théroux, A. Bouchard, 1985, Journal of the American College of Cardiology.

Aspirin Versus Heparin to Prevent Myocardial Infarction During the Acute Phase of Unstable Angina

D. Waters, P. Théroux, J. Mccans, 1993, Circulation.

Relation of Variability of Low-Density Lipoprotein Cholesterol and Blood Pressure to Events in Patients With Previous Myocardial Infarction from the IDEAL Trial.

D. Waters, S. Bangalore, F. Messerli, 2017, The American journal of cardiology.

Meta-analyses of statin trials: clear benefit for primary prevention in the elderly.

D. Waters, 2013, Journal of the American College of Cardiology.

LDL-cholesterol lowering and renal outcomes

D. Waters, 2015, Current opinion in lipidology.

Relation of improvement in estimated glomerular filtration rate with atorvastatin to reductions in hospitalizations for heart failure (from the Treating to New Targets [TNT] study).

D. Waters, K. Khush, P. Deedwania, 2012, The American journal of cardiology.

Long-term prognosis of patients with incomplete bilateral bundle branch block complicating acute myocardial infarction. Role of cardiac pacing.

D. Waters, H. Mizgala, 1974, The American journal of cardiology.

Programmed ventricular stimulation in survivors of an acute myocardial infarction.

D. Waters, M. Bourassa, P. Théroux, 1985, Circulation.

Increasing age, female sex and anterior infarction are significant risk factors for developing ventricular septal defect after acute myocardial infarction

D. Waters, S. Cooley, 2000 .

Prospects for beyond the Standard Model physics searches at the Deep Underground Neutrino Experiment

J. I. Crespo-Anad'on, V. P. Luzio, P. Baldi, 2020, The European Physical Journal. C, Particles and Fields.

Deep Underground Neutrino Experiment (DUNE), Far Detector Technical Design Report, Volume II: DUNE Physics

V. P. Luzio, J. I. Crespo-Anadón, P. Baldi, 2020, 2002.03005.

Supernova Neutrino Burst Detection with the Deep Underground Neutrino Experiment

J. I. Crespo-Anad'on, V. P. Luzio, P. Baldi, 2020, 2008.06647.

Long-baseline neutrino oscillation physics potential of the DUNE experiment

J. I. Crespo-Anad'on, V. P. Luzio, P. Baldi, 2020, 2006.16043.

The Single-Phase ProtoDUNE Technical Design Report

T. V. Vieira, D. P. Méndez, F. R. Torres, 2017, 1706.07081.

Deep Underground Neutrino Experiment (DUNE) Near Detector Conceptual Design Report

J. I. Crespo-Anad'on, V. P. Luzio, P. Baldi, 2021, 2103.13910.

Progression of Atherosclerosis as Assessed by Carotid Intima-Media Thickness in Patients With HIV Infection

Jeffrey N. Martin, A. Bolger, D. Waters, 2004, Circulation.

Clinical Features of Acute Coronary Syndromes in Patients With Human Immunodeficiency Virus Infection

D. Waters, S. Erickson, N. Younes, 2004, Circulation.

Top-quark mass measurement in events with jets and missing transverse energy using the full CDF data set

D. Whiteson, T. Aaltonen, S. Amerio, 2013, 1305.3339.

Measurement of the top quark mass in the dilepton channel using m(T2) at CDF

D. Whiteson, V. Ramakrishnan, M. Feindt, 2010 .

First simultaneous measurement of the top quark mass in the lepton + jets and dilepton channels at CDF

D. Whiteson, V. Ramakrishnan, M. Feindt, 2009 .

A randomized controlled trial of smoking cessation counseling after myocardial infarction.

P. Thompson, D. Waters, E. Dornelas, 2000, Preventive medicine.

Acute Aortic Dissection Related to Crack Cocaine

A. Bolger, D. Waters, P. Hsue, 2002, Circulation.

Statin and the risk of renal-related serious adverse events: Analysis from the IDEAL, TNT, CARDS, ASPEN, SPARCL, and other placebo-controlled trials.

D. Waters, S. Bangalore, G. Hovingh, 2014, The American journal of cardiology.

Effects of monotherapy with an HMG-CoA reductase inhibitor on the progression of coronary atherosclerosis as assessed by serial quantitative arteriography. The Canadian Coronary Atherosclerosis Intervention Trial.

D. Waters, M. Le May, B. Kimball, 1994, Circulation.

Effects of statin therapy on the development and progression of heart failure: mechanisms and clinical trials.

D. Waters, K. Khush, 2006, Journal of cardiac failure.

Review Article Effects of Statin Therapy on the Development and Progression of Heart Failure: Mechanisms and Clinical Trials

D. Waters, K. Khush, 2006 .

Effect of Lowering LDL Cholesterol Substantially Below Currently Recommended Levels in Patients With Coronary Heart Disease and Diabetes

J. Hsia, S. Grundy, P. Barter, 2006, Diabetes Care.

Variations in time to benefit among clinical trials of cholesterol-lowering drugs.

P. Barter, D. Waters, 2018, Journal of clinical lipidology.

Epidemiology and Prevention Effect of Torcetrapib on Glucose, Insulin, and Hemoglobin A 1c in Subjects in the Investigation of Lipid Level Management to Understand its Impact in Atherosclerotic Events (ILLUMINATE) Trial

P. Barter, J. Tardif, D. Waters, 2011 .

Rationale, design, and baseline characteristics of a trial comparing aggressive lipid lowering with Atorvastatin Versus Revascularization Treatments (AVERT).

D. Waters, B. Pitt, W. V. Brown, 1997, The American journal of cardiology.

Early results, complications and restenosis rates after multilesion and multivessel percutaneous transluminal coronary angioplasty.

D. Waters, M. Lambert, R. Bonan, 1987, The American journal of cardiology.

Percutaneous transluminal coronary angioplasty for the treatment of variant angina.

D. Waters, M. Bourassa, P. David, 1985, Journal of the American College of Cardiology.

Percutaneous Transluminal Coronary Angioplasty in Patients with Variant Angina

D. Waters, M. Bourassa, J. Szlachcic, 1982, Circulation.

Synergy between intracoronary stenting and abciximab in improving angiographic and clinical outcomes of primary angioplasty in acute myocardial infarction.

D. Waters, J. Hirst, R. McKay, 2000, The American journal of cardiology.

Short- and medium-term outcome differences in women and men after primary percutaneous transluminal mechanical revascularization for acute myocardial infarction.

D. Waters, J. Hirst, R. McKay, 2000, The American journal of cardiology.

A new look at coronary angiograms: plaque morphology as a help to diagnosis and to evaluate outcome

D. Waters, P. Théroux, G. Hudon, 1994, The International Journal of Cardiac Imaging.

Clinical and angiographic characteristics of exertion-related acute myocardial infarction.

J. Clive, P. Thompson, D. Waters, 1999, JAMA.

Myocardial Infarction in the ISCHEMIA Trial: Impact of Different Definitions on Incidence, Prognosis, and Treatment Comparisons.

Sean M. O'Brien, K. Alexander, H. White, 2020, Circulation.

Prediction of Multivessel Disease after Inferior Myocardial Infarction

B. Chaitman, D. Waters, M. Bourassa, 1978, Circulation.

Clinical predictors of angina following myocardial infarction.

D. Waters, C. Halphen, H. Mizgala, 1979, The American journal of medicine.

Exercise testing after myocardial infarction: a perspective.

D. Waters, 1986, Journal of the American College of Cardiology.

Clinical and Angiographic Correlates of Exercise‐induced ST‐segment Elevation: Increased Detection with Multiple ECG Leads

B. Chaitman, D. Waters, M. Bourassa, 1980, Circulation.

Detection of Multivessel Coronary Disease After Myocardial Infarction Using Exercise Stress Testing and Multiple ECG Lead Systems

B. Chaitman, D. Waters, M. Bourassa, 1980, Circulation.

Design features of a controlled clinical trial to assess the effect of an HMG CoA reductase inhibitor on the progression of coronary artery disease. Canadian Coronary Atherosclerosis Intervention Trial Investigators Montreal, Ottawa, and Toronto, Canada.

D. Waters, B. Kimball, L. Higginson, 1993, Controlled clinical trials.

Progression and regression of coronary atherosclerosis: data from a controlled clinical trial with nicardipine

D. Waters, J. Lésperance, 1993 .

Comparison by quantitative angiographic assessment of coronary stenoses of one view showing the severest narrowing to two orthogonal views.

C. White, D. Waters, C W White, 1989, The American journal of cardiology.

Hemodynamic effects of calcium ion antagonists after acute myocardial infarction.

D. Waters, M. Bourassa, P. Théroux, 1980, Clinical and investigative medicine. Medecine clinique et experimentale.

Women's angiographic vitamin and estrogen trial: design and methods.

J. Hsia, M. Proschan, D. Gordon, 2002, Controlled clinical trials.

Plasma Lipoproteins and Progression of Coronary Artery Disease Evaluated by Angiography and Clinical Events

D. Waters, R. Havel, N. Phillips, 1993, Circulation.

Reversibility and pathohistological basis of left ventricular remodeling in hibernating myocardium.

D. Waters, J. Fallon, L. Gillam, 2000, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

Impact of delayed reperfusion of myocardial hibernation on myocardial ultrastructure and function and their recoveries after reperfusion in a pig model of myocardial hibernation.

D. Waters, J. Fallon, L. Gillam, 2000, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

Functional and structural alterations with 24-hour myocardial hibernation and recovery after reperfusion. A pig model of myocardial hibernation.

D. Waters, J. Fallon, L. Bow, 1996, Circulation.

Incremental doses of dobutamine induce a biphasic response in dysfunctional left ventricular regions subtending coronary stenoses.

A. Weyman, D. Waters, J. Fallon, 1995, Circulation.

Preoperative coronary artery disease risk stratification based on dipyridamole imaging and a simple three-step, three-segment model for patients undergoing noncardiac vascular surgery or major general surgery.

D. Waters, J. Lette, M. Cerino, 1992, The American journal of cardiology.

Prognostic implications of a negative dipyridamole-thallium scan: results in 360 patients.

D. Waters, J. Lette, M. Cerino, 1992, The American journal of medicine.

Usefulness of the severity and extent of reversible perfusion defects during thallium-dipyridamole imaging for cardiac risk assessment before noncardiac surgery.

D. Waters, J. Lette, M. Cerino, 1989, The American journal of cardiology.

Women Do Benefit from Lipid Lowering: Latest Clinical Trial Data

D. Waters, E. Mostaghel, 2003, Cardiology in review.

Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: A randomized controlled trial

J. Hsia, M. Proschan, D. Gordon, 2002 .

Uncomplicated non-Q wave infarction caused by total obstruction of the left main coronary artery.

D. Waters, C. Pelletier, M. Chabot, 1987, American heart journal.

Effect of low grade radiofrequency heating on arterial vasospasm in the porcine model.

D. Waters, R. McKay, D B Fram, 1997, Catheterization and cardiovascular diagnosis.

Unstable angina and progression of coronary atherosclerosis.

D. Waters, M. Bourassa, P. Théroux, 1983, The New England journal of medicine.

Is there a simple way to identify insulin-resistant individuals at increased risk of cardiovascular disease?

R. Krauss, T. McLaughlin, C. Lamendola, 2005, The American journal of cardiology.

Angiographic findings after myocardial infarction in patients with previous bypass surgery: explanations for smaller infarcts in this group compared with control patients.

D. Waters, P. Théroux, P. Crean, 1985, Circulation.

Early pharmacologic intervention and plaque stability in acute coronary syndromes.

D. Waters, David D. Waters, 2001, The American journal of cardiology.

What is the role of intensive cholesterol lowering in the treatment of acute coronary syndromes?

D. Waters, P. Hsue, 2001, The American journal of cardiology.

Effects of Cigarette Smoking on the Angiographic Evolution of Coronary Atherosclerosis: A Canadian Coronary Atherosclerosis Intervention Trial (CCAIT) Substudy

D. Waters, L. Higginson, P. Gladstone, 1996 .

Management of the acute coronary syndrome patient

D. Waters, K. Khush, 2004 .

Clinical and Angiographic Factors Associated With Coronary Artery Disease Progression of Coronary Artery Disease

Yves Taeymans, D. Waters, P. Finès, 1984 .

The Importance of Clinical Subsets in Interpreting Maximal Treadmill Exercise Test Results: the Role of Multiple-Lead ECG Systems

B. Chaitman, D. Waters, M. Bourassa, 1979, Circulation.

Racial differences of lipoprotein subclass distributions in postmenopausal women.

J. Tardif, D. Waters, V. Bittner, 2008, Ethnicity & disease.

Factors influencing the long-term prognosis of treated patients with variant angina.

D. Waters, D. Miller, P. Théroux, 1983, Circulation.

Predictive value and safety of low level exercise tolerance testing early after acute myocardial infarction

D. Waters, C. Halphen, H. Mizgala, 1978 .

In vivo radiofrequency thermal balloon angioplasty of porcine coronary arteries: histologic effects and safety.

D. Waters, L. Gillam, R. McKay, 1993, American heart journal.

PRINCE's prospects: statins, inflammation, and coronary risk.

D. Waters, R. Azar, 2001, American heart journal.

Cholesterol lowering. Should it continue to be the last thing we do?

D. Waters, 1999, Circulation.

Factors associated with the release of cardiac troponin T following percutaneous transluminal coronary angioplasty

D. Waters, A. Wu, R. McKay, 1996, Clinical cardiology.

Body‐Weight Fluctuations and Outcomes in Coronary Disease

D. Waters, S. Bangalore, F. Messerli, 2017, The New England journal of medicine.

Search for Charged Higgs Bosons in Decays of Top Quarks in pp̅ Collisions at √s=1.96 TeV

G. P. Yeh, D. Whiteson, V. Ramakrishnan, 2009 .

Differences in Medical Care and Disease Outcomes Among Black and White Women With Heart Disease

Mark A Hlatky, C. Furberg, A. Jha, 2003, Circulation.

Charged jet evolution and the underlying event in proton-antiproton collisions at 1.8 TeV

A. Ribon, Stephen R. Leone, Paola Grosso, 2002, Physical Review D.

Search for heavy metastable particles decaying to jet pairs in pp̄ collisions at √s=1.96TeV

M. Dorigo, D. Whiteson, V. Ramakrishnan, 2012 .

Search for a Higgs boson in the diphoton final state using the full CDF data set from pp collisions at s=1.96TeV

M. Dorigo, D. Whiteson, V. Ramakrishnan, 2012 .

Impact of Diabetes on the Risk Stratification Using Stress Single-Photon Emission Computed Tomography Myocardial Perfusion Imaging in Patients With Symptoms Suggestive of Coronary Artery Disease

D. Berman, L. Shaw, D. Waters, 2002, Circulation.

Lipid Treatment Assessment Project 2: A Multinational Survey to Evaluate the Proportion of Patients Achieving Low-Density Lipoprotein Cholesterol Goals

K. Seung, D. Waters, J. Jukema, 2009, Circulation.

Search for a new heavy gauge boson W' with event signature electron plus missing transverse energy in p(p)over-bar collisions at root s=1.96 TeV

D. Whiteson, V. Ramakrishnan, M. Feindt, 2011 .

Design features of a controlled clinical trial to assess the effect of a calcium entry blocker upon the progression of coronary artery disease.

D. Waters, P. Théroux, G. Gosselin, 1987, Controlled clinical trials.

Search for a Standard Model Higgs Boson in WH -> lvbb in pp Collisions at s=1.96 TeV

Stephen R. Leone, S. Wolbers, E. Lipeles, 2009 .

Quantitation of myocardial dysfunction in ischemic heart disease by echocardiographic endocardial surface mapping: correlation with hemodynamic status.

D. Waters, M. Picard, L. Gillam, 1995, American heart journal.

Predicting Prognosis in Acute Coronary Syndromes: Makeover Time for TIMI and GRACE?

D. Waters, B. Arsenault, 2016, The Canadian journal of cardiology.

SUDDEN DEATH Programmed ventricular stimulation in survivors of an acute myocardial infarction

D. Waters, M. Bourassa, E. Marchand, 2005 .

Hemodynamic effects of a single oral dose of nifedipine following acute myocardial infarction.

D. Waters, H. Mizgala, P. Théroux, 1980, Chest.

Forward-Backward Asymmetry in Top-Quark Production in p(p)over-bar Collisions at root s=1.96 TeV RID G-1087-2011 RID E-4473-2011

Cavaliere, Krutelyov, Rekovic, 2008 .

Deep Underground Neutrino Experiment (DUNE), Far Detector Technical Design Report, Volume IV Far Detector Single-phase Technology

V. P. Luzio, J. I. Crespo-Anadón, P. Baldi, 2020, 2002.03010.

Top quark mass measurement using the template method in the lepton + jets channel at CDF II

G. P. Yeh, D. Whiteson, M. Feindt, 2006 .

Inclusive search for new physics with like-sign dilepton events in p(p)over-bar collisions at root s=1.96 TeV

Krutelyov, Rekovic, Khotilovich, 2007 .

Myocardial ischemia: detection and quantitation.

D. Waters, J. Forrester, 1978, Annals of internal medicine.

Search for neutral Higgs bosons in events with multiple bottom quarks at the Tevatron

R. K. Shivpuri, M. Dorigo, D. Whiteson, 2012 .

Search for Higgs bosons produced in association with b quarks

Stephen R. Leone, W. Ketchum, S. Lockwitz, 2012 .

Determinants of Residual Risk in Secondary Prevention Patients Treated With High- Versus Low-Dose Statin Therapy: The Treating to New Targets (TNT) Study

D. Waters, P. Deedwania, S. Mora, 2012, Circulation.

Residual risk in TNT

D. Waters, P. Deedwania, S. Mora, 2012 .

Measurement of the J/psi meson and b-hadron production cross sections in p(p)over-bar collisions at root s=1960 GeV RID C-1693-2008 RID G-1087-2011 RID E-4473-2011

Krutelyov, Rekovic, Khotilovich, 2005 .

Measurement of b-jet shapes in inclusive jet production in pp̄ collisions at s=1.96TeV

D. Whiteson, V. Ramakrishnan, M. Feindt, 2008 .

The DUNE Far Detector Interim Design Report, Volume 3: Dual-Phase Module

D. P. Méndez, J. I. Crespo-Anad'on, V. P. Luzio, 2018, 1807.10340.

Underlying event in hard interactions at the Fermilab Tevatron [Formula Presented] collider

M. Spiropulu, M. Albrow, D. Amidei, 2004 .

Search for Pair Production of Supersymmetric Top Quarks in Dilepton Events from p(p)over-bar Collisions at root s=1.96 TeV

D. Whiteson, V. Ramakrishnan, M. Feindt, 2010 .

Treating to New Targets (TNT) Study: does lowering low-density lipoprotein cholesterol levels below currently recommended guidelines yield incremental clinical benefit?

D. Waters, C. Shear, D. Herrington, 2004, The American journal of cardiology.

Preventing and treating stroke and transient ischemic attack.

D. Waters, D. Defaria Yeh, 2008, The American journal of cardiology.

Search for High Mass Resonances Decaying to Muon Pairs in root s=1.96 TeV p(p)over-bar Collisions

Cavaliere, Krutelyov, Khotilovich, 2011 .

Patients by Lipid and Nonlipid Biomarkers Prediction of Cardiovascular Events in Statin-Treated Stable Coronary

S. Grundy, P. Barter, D. Waters, 2012 .

Long-term reproducibility and significance of provokable ventricular arrhythmias after myocardial infarction.

D. Waters, M. Bourassa, P. Théroux, 1986, Journal of the American College of Cardiology.

Pulse Pressure and Coronary Atherosclerosis Progression in Postmenopausal Women

David M Herrington, D. Waters, D. Herrington, 2005, Hypertension.

Reaching C-reactive protein and low-density lipoprotein cholesterol goals in dyslipidemic patients (from the Lipid Treatment Assessment Project [L-TAP] 2).

K. Seung, D. Waters, J. Jukema, 2011, The American journal of cardiology.

Measurement of particle production and inclusive differential cross sections in p(p)over-bar collisions at root s=1.96 TeV

Cavaliere, Krutelyov, Khotilovich, 2009 .

Postmenopausal Hormone Therapy Is Associated With Atherosclerosis Progression in Women With Abnormal Glucose Tolerance

J. Hsia, B. Howard, D. Waters, 2004, Circulation.

ImpactofSmokingonCardiovascularEventsinPatientsWithStableCoronaryDiseaseReceiving ContemporaryMedicalTherapy:APostHocAnalysisoftheTreatingtoNewTargetsTrial

D. Waters, A. Breazna, D. Demicco, 2010 .

Effects of the high-density lipoprotein mimetic agent CER-001 on coronary atherosclerosis in patients with acute coronary syndromes: a randomized trial

M. Pfeffer, C. Grines, R. D. de Winter, 2014, European heart journal.

Cardiac arrest in patients who smoke crack cocaine.

D. McManus, D. Waters, N. Younes, 2007, The American journal of cardiology.

Comparison of electrocardiographic-gated technetium-99m sestamibi single-photon emission computed tomographic imaging and rest-redistribution thallium-201 in the prediction of myocardial viability.

M. G. Levine, D. Waters, G. Heller, 2000, The American journal of cardiology.

PCSK9 Inhibition to Reduce Cardiovascular Risk: Tempering Expectations.

D. Waters, P. Hsue, 2017, Circulation research.

A pr 2 00 7 February 1 , 2008 Simulation of Ultra High Energy Neutrino Interactions in Ic e and Water ( the ACoRNE Collaboration ) a

D. Waters, L. Thompson, T. Sloan, 2007 .

Measurement of the Lambda(0)(b) lifetime in Lambda(0)(b)-> J/psi Lambda(0) in p(p)over-bar collisions at root s=1.96 TeV RID G-1087-2011 RID E-4473-2011

Krutelyov, Rekovic, Khotilovich, 2007 .

Search for exotic S =-2 baryons in p(p)over-bar collisions at root s=1.96 TeV

Krutelyov, Rekovic, Khotilovich, 2006 .

Deep Underground Neutrino Experiment (DUNE), Far Detector Technical Design Report, Volume III DUNE Far Detector Technical Coordination

V. P. Luzio, J. I. Crespo-Anadón, P. Baldi, 2020, 2002.03008.

First Measurement of the Ratio of Branching Fractions B(Lambda0(b) ---> Lambda+(c) mu- anti-nu(mu)) / B(Lambda0(b) ---> Lambda+(c) pi-)

J. P. Fernández, Robert M. Harris, D. Whiteson, 2008 .

Multivariate clinical models and quantitative dipyridamole-thallium imaging to predict cardiac morbidity and death after vascular reconstruction.

S. Nattel, D. Waters, J. Lette, 1991, Journal of vascular surgery.

Non-invasive pulsed Doppler study of mitral stenosis and mitral regurgitation: preliminary study.

D. Waters, M. Bourassa, B. Diebold, 1979, British heart journal.

In search of the origin of mass

B. Heinemann, T. Shears, D. Waters, 2006, Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences.

A search for correlation of ultra-high energy cosmic rays with IRAS-PSCz and 2MASS-6dF galaxies

Shaun A. Thomas, O. Lahav, F. Abdalla, 2012, 1207.4043.

Early changes in regional and global left ventricular function induced by graded reductions in regional coronary perfusion.

D. Waters, J. Forrester, H. Swan, 1977, The American journal of cardiology.

Search for the Decays B(s)-->e+mu- and B(s)-->e+e- in CDF Run II

D. Whiteson, V. Ramakrishnan, M. Feindt, 2009 .

Search forBs0→μ+μ−andB0→μ+μ−Decays with2fb−1ofpp¯Collisions

Stephen R. Leone, M. Soderberg, S. Wolbers, 2008 .

Left-to-right atrial shunting after percutaneous mitral valvuloplasty. Incidence and long-term hemodynamic follow-up.

D. Waters, I. Dyrda, R. Bonan, 1990, Circulation.

Cardiovascular outcomes during 6.8 years of hormone therapy: Heart and Estrogen/Progestin Replacement Study follow-up (HERS II)

E. Vittinghoff, J. Hsia, L. Newby, 2002 .

Does prevalence of the metabolic syndrome in women with coronary artery disease differ by the ATP III and IDF criteria?

B. Howard, J. Tardif, D. Waters, 2008, Journal of women's health.

Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women. A randomized controlled trial

J. Hsia, D. Waters, E. Alderman, 2003 .

Visit-to-visit variability of lipid measurements as predictors of cardiovascular events.

P. Barter, D. Waters, S. Bangalore, 2017, Journal of clinical lipidology.

Metabolic Markers to Predict Incident Diabetes Mellitus in Statin-Treated Patients (from the Treating to New Targets and the Stroke Prevention by Aggressive Reduction in Cholesterol Levels Trials).

J. Knowles, D. Waters, G. Reaven, 2016, The American journal of cardiology.

2013 Cholesterol Guidelines Revisited: Percent LDL Cholesterol Reduction or Attained LDL Cholesterol Level or Both for Prognosis?

D. Waters, S. Bangalore, J. Kastelein, 2016, The American journal of medicine.

Impact of female sex on lipid lowering, clinical outcomes, and adverse effects in atorvastatin trials.

D. Waters, N. Wenger, V. Bittner, 2015, The American journal of cardiology.

Prediction of Cardiovascular Events in Statin-Treated Stable Coronary Patients of the Treating to New Targets Randomized Controlled Trial by Lipid and Non-Lipid Biomarkers

S. Grundy, P. Barter, D. Waters, 2014, PloS one.

Erratum: Prediction of cardiovascular events in statin-treated patients by lipid and non-lipid biomarkers (Journal of the American College of Cardiology (2011) 57 (63-69))

S. Grundy, P. Barter, D. Waters, 2013 .

The 719Arg Variant of KIF6 and Cardiovascular Outcomes in Statin-Treated, Stable Coronary Patients of the Treating to New Targets and Incremental Decrease in End Points Through Aggressive Lipid-Lowering Prospective Studies

P. Barter, J. Kastelein, D. Waters, 2012, Circulation. Cardiovascular genetics.

Cost Effectiveness of Intensive Lipid-Lowering Treatment for Patients with Congestive Heart Failure and Coronary Heart Disease in the US

M. Drummond, M. Weinstein, D. Waters, 2010, PharmacoEconomics.

Lipid goals among patients with diabetes or metabolic syndrome: Lipid Treatment Assessment Project (L-TAP) 2

D. Waters, J. Jukema, J. Ferrières, 2010, Current medical research and opinion.

Comparison of lipid profiles and attainment of lipid goals in patients <65 years versus patients ≥65 years (from the Lipid Treatment Assessment Project [L-TAP] 2).

D. Waters, J. Jukema, J. Ferrières, 2012, The American journal of cardiology.

Erratum: Novel inclusive search for the Higgs boson in the four-lepton final state at CDF (Physical Review D (2012) 86 (072012) DOI:10.1103/PhysRevD. 86.072012)

M. Dorigo, D. Whiteson, V. Ramakrishnan, 2012 .

Model-Independent Global Search for New High-pT Physics at CDF

J. P. Fernández, Neubauer, Robert M. Harris, 2007 .

Production of Λ0, Λ ̄0, Ξ ±, and Ω± hyperons in pp̄ collisions at √s=1.96TeV

D. Whiteson, V. Ramakrishnan, M. Feindt, 2012 .

Pharmacogenomics of the Efficacy and Safety of Colchicine in COLCOT

R. Diaz, J. Tardif, D. Waters, 2021, Circulation. Genomic and precision medicine.

Transient left ventricular cavitary dilation during dipyridamole-thallium imaging as an indicator of severe coronary artery disease.

D. Waters, J. Lette, M. Cerino, 1990, The American journal of cardiology.

Pulsed Doppler Echocardiographic Study of Mitral Stenosis

D. Waters, M. Bourassa, P. Peronneau, 1980, Circulation.

Study of the heavy flavor content of jets produced in association with W bosons in p(p)over-bar collisions at root s=1.8 TeV

Shapiro, M. Spiropulu, D. Amidei, 2002 .

Carotid intima-media thickness among human immunodeficiency virus-infected patients without coronary calcium.

Jeffrey N. Martin, D. Waters, P. Ganz, 2012, The American journal of cardiology.

Polarizations of J/psi and psi(2S) mesons produced in p(p)over-bar collisins at root s-1.96 TeV RID G-1087-2011 RID E-4473-2011

Krutelyov, Rekovic, Khotilovich, 2007 .

Measurement of J/psi and psi(2S) polarization in p(p)over-bar collisions at root s=1.8 TeV RID C-1693-2008 RID A-5169-2010 RID C-2406-2008

Amendolia, Shapiro, Glagolev, 2000 .

Search for standard model Higgs boson production in association with a W boson at CDF RID G-1087-2011 RID E-4473-2011

Cavaliere, Krutelyov, Rekovic, 2008 .

Search for new physics in the mu mu+e/mu + is not an element of T channel with a low-pT lepton threshold at the Collider Detector at Fermilab

D. Whiteson, V. Ramakrishnan, M. Feindt, 2008 .

Exercise-induced myocardial ischemia in a cold environment. Effect of antianginal medications.

D. Waters, M. Juneau, M. Johnstone, 1989, Circulation.

Advantages and limitations of serial coronary arteriography for the assessment of progression and regression of coronary atherosclerosis. Implications for clinical trials.

D. Waters, T. Craven, L. Gillam, 1993, Circulation.

Experiment Simulation Configurations Approximating DUNE TDR

J. I. Crespo-Anad'on, V. P. Luzio, P. Baldi, 2021, 2103.04797.

Remodeling of Small Intramyocardial Coronary Arteries Distal to a Severe Epicardial Coronary Artery Stenosis

D. Waters, J. Fallon, Chunguang Chen, 2002, Arteriosclerosis, thrombosis, and vascular biology.

Lessons from the PROVE-IT trial. Higher dose of potent statin better for high-risk patients.

D. Waters, K. Khush, 2004, Cleveland Clinic journal of medicine.

Effect of atorvastatin, cholesterol ester transfer protein inhibition, and diabetes mellitus on circulating proprotein subtilisin kexin type 9 and lipoprotein(a) levels in patients at high cardiovascular risk.

P. Barter, D. Waters, J. Kastelein, 2017, Journal of clinical lipidology.

Effect of diltiazem upon episodes of silent myocardial ischemia during daily life

D. Waters, M. Baird, M. Juneau, 1990 .

Effect of Diltiazem on Symptomatic and Asymptomatic Episodes of ST Segment Depression Occurring During Daily Life and During Exercise

D. Waters, M. Baird, M. Juneau, 1991, Circulation.

Comparison of exercise, dipyridamole, adenosine, and dobutamine stress with the use of Tc-99m tetrofosmin tomographic imaging

M. G. Levine, D. Waters, G. Heller, 1999, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

Myocardial infarction in patients with previous coronary artery bypass surgery.

D. Waters, P. Théroux, L. Campeau, 1984, Journal of the American College of Cardiology.

Tests of enhanced leading order QCD in W boson plus jets events from 1.8 TeV p̅p collisions

M. Spiropulu, M. Albrow, D. Amidei, 2001 .

Measurement of theΛb0Lifetime inΛb0→J/ψΛ0inpp¯Collisions ats=1.96TeV

D. Whiteson, M. Feindt, J. Adelman, 2007 .

The Rise and Fall of Tuberculosis and Atherosclerosis: First There Is a Mountain….

D. Waters, 2017, The Canadian journal of cardiology.

Performance Deficiencies in the Treatment of ST-Elevation Myocardial Infarction in Québec: "Tis But a Part We See, and Not a Whole".

D. Waters, R. Azar, Z. Kadri, 2016, The Canadian journal of cardiology.

W-boson polarization measurement in the t(t)over-bar dilepton channel using the CDF II detector

M. Dorigo, D. Whiteson, V. Ramakrishnan, 2013 .

Effects of beta-blockade and atropine on ischemic responses in left ventricular regions subtending coronary stenosis during dobutamine stress echocardiography.

D. Waters, M. Chen, L. Gillam, 1996, Journal of the American College of Cardiology.

Factors associated with progression of coronary artery disease in patients with normal or minimally narrowed coronary arteries.

D. Waters, P. Théroux, Y. Taeymans, 1985, The American journal of cardiology.

D. Waters, L. Gillam, A. Parke, 1997, The Canadian journal of cardiology.

UNMET NEEDS IN THE PREVENTION OF ASCVD: A SINGAPORE PERSPECTIVE

D. Waters, C. F. Liew, J. Choo, 2016 .

Searches for the Higgs boson decaying to W+W -→ℓ+νℓ-ν̄ with the CDF II detector

M. Dorigo, D. Whiteson, S. Amerio, 2013, 1306.0023.

Precision top-quark mass measurement in the lepton plus jets topology in p(p)over-bar collisions at root s=1.96 TeV

Krutelyov, Rekovic, Khotilovich, 2006 .

Measurement of the top quark mass in the lepton plus jets channel using the lepton transverse momentum RID G-1087-2011 RID E-4473-2011

Cavaliere, Krutelyov, Khotilovich, 2011 .

The ergonovine test--to catch a leprechaun.

D. Waters, P. Théroux, 1983, International journal of cardiology.

A winter's tale: report from the First Annual Canadian Biomarkers and Surrogate Endpoints Symposium.

P. Libby, J. Tardif, D. Waters, 2009, The Canadian journal of cardiology.

Erratum: Measurement of the inclusive jet cross section in pp collisions at √s= 1.8 Tev (Physical Review D- Particles, Fields, Gravitation and Cosmology (2001) 64 (032001)

M. Spiropulu, M. Albrow, D. Amidei, 2002 .

A comparative study of calcium-ion antagonists in patients with variant angina.

D. Waters, J. Szlachcic, H. Mizgala, 1980, Clinical and investigative medicine. Medecine clinique et experimentale.

A dose-ranging, placebo-controlled, double-blind trial of nisoldipine in effort angina: duration and extent of antianginal effects.

B R Chaitman, B. Chaitman, D. Waters, 1985, Journal of the American College of Cardiology.

Search for a heavy vector boson decaying to two gluons in pp̄ collisions at √s=1.96TeV

M. Dorigo, D. Whiteson, V. Ramakrishnan, 2012 .

Soft and hard interactions in p(p)over-bar collisions at root s=1800 and 630 GeV RID C-1693-2008 RID A-5169-2010 RID E-4473-2011 RID C-2406-2008

Shapiro, Glagolev, M. Spiropulu, 2002 .

No effect of long-term hormone replacement on brachial flow-mediated vasodilation in the estrogen replacement and atherosclerosis trial

D. Reboussin, D. Waters, D. Herrington, 2000 .

Search for new physics in lepton plus photon plus X events with 305 pb(-1) of p(p)over-bar collisions at root s=1.96 TeV

Krutelyov, Rekovic, Khotilovich, 2006 .

Prevention of progression of minimal coronary lesions with a calcium channel blocker

D. Waters, R. Havel, M. Reitman, 1990 .

Diffractive dijet production at sqrt[s] = 630 and 1800 GeV at the Fermilab Tevatron.

M. Spiropulu, M. Albrow, D. Amidei, 2001, Physical review letters.

Measurement of the D+ -meson production cross section at low transverse momentum in pp# collisions at √s p = 1.96 TeV

D. Whiteson, T. Aaltonen, S. Amerio, 2022 .

Inclusive Search for Squark and Gluino Production in p(p)over-bar Collisions at root s = TeV RID G-1087-2011 RID E-4473-2011

Cavaliere, Krutelyov, Rekovic, 2009 .

Aortic and mitral valve replacement in a patient with osteogenesis imperfecta.

D. Waters, R. Schlant, D. W. Clark, 1977, Chest.

Low-molecular-weight heparins for unstable angina. A better mousetrap?

D. Waters, R. Azar, 1997, Circulation.

Measurement of σ(pp̄→Z)·B(Z→ττ) in pp̄ collisions at s=1.96TeV

D. Whiteson, M. Feindt, J. Adelman, 2007 .

Measurement of W and Z production in pp̄ collisions at √s = 1.96 TeV

Krutelyov, Rekovic, Khotilovich, 2005 .

VITAMIN D LEVELS DO NOT PREDICT CARDIOVASCULAR EVENTS IN STATIN-TREATED PATIENTS WITH STABLE CORONARY DISEASE

D. Waters, N. Wenger, D. Demicco, 2010 .

Search for Color Singlet Technicolor Particles in p p̄ Collisions at √s = 1.8 Te V

M. Spiropulu, M. Albrow, D. Amidei, 2000 .

Search for supersymmetric partner of the top-quark in p anti-p collisions at s**(1/2) = 1.8 TeV

Shapiro, M. Spiropulu, M. Albrow, 2001 .

Doctors’ knowledge, attitudes, and compliance with 2013 ACC/AHA guidelines for prevention of atherosclerotic cardiovascular disease in Singapore

D. Waters, S. Setia, Selwyn Fung, 2015, Vascular health and risk management.

Notes From Cardiology Clinic: The Heartbreaking Risk Factor We Overlook.

D. Waters, 2020, The Canadian journal of cardiology.

Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: a randomized controlled trial.

J. Hsia, M. Proschan, D. Gordon, 2002, JAMA.

Measurement of the top quark mass using template methods on dilepton events in p(p)over-bar collisions at root s=1.96 TeV RID C-3493-2011 RID G-1087-2011 RID E-4473-2011

Krutelyov, Rekovic, Khotilovich, 2006 .

Measurements of branching fraction ratios and {$\mathit{CP}$}-asymmetries in suppressed {$B^{-} \to D(\to K^+\pi^-)K^{-}$} and {$B^{-} \to D(\to K^+\pi^-)\pi^{-}$} decays

M. Dorigo, D. Whiteson, V. Ramakrishnan, 2011 .

Search for Anomalous Production of Events with Two Photons and Additional Energetic Objects at CDF

D. Whiteson, V. Ramakrishnan, M. Feindt, 2010 .

Search for anomalous production of events with a photon, jet, b-quark jet, and missing transverse energy

D. Whiteson, V. Ramakrishnan, M. Feindt, 2009 .

Strong evidence for ZZ production in pp̄ collisions at s=1.96TeV

M. Soderberg, S. Wolbers, E. Lipeles, 2008 .

Lipid Abnormalities in Persons Living With HIV Infection.

D. Waters, P. Hsue, 2019, The Canadian journal of cardiology.

Introduction to Cardiovascular Issues in HIV.

D. Waters, P. Hsue, 2019, The Canadian journal of cardiology.

Statin-centric versus low-density lipoprotein-centric approach for atherosclerotic cardiovascular disease prevention: a Singapore perspective.

D. Waters, C. F. Liew, J. Choo, 2016, Singapore medical journal.

Searches for the Higgs boson decaying to W[superscript +]W[superscript -] → ℓ[superscript +]νℓ[superscript -][¯ over v] with the CDF II detector

M. Dorigo, D. Whiteson, T. Aaltonen, 2013 .

Volume I. Introduction to DUNE

V. P. Luzio, J. I. Crespo-Anadón, P. Baldi, 2020, Journal of Instrumentation.

Regression of coronary atherosclerosis: A prospective, quantitative angiographic study

D. Waters, G. Hudon, J. Lésperance, 1991 .

Measurements of inclusive W and Z cross sections in p(p)over-bar collisions at root s=1.96 TeV

D. Whiteson, M. Feindt, J. Adelman, 2005, hep-ex/0508029.

PCSK9 Inhibition to Lower LDL-Cholesterol and Reduce Cardiovascular Risk: Great Expectations.

D. Waters, P. Hsue, 2015, Circulation research.

Exercise Testing in Patients with Variant Angina: Results, Correlation with Clinical and Angiographic Features and Prognostic Significance

D. Waters, M. Bourassa, J. Szlachcic, 1982, Circulation.

Measurement of central exclusive π+π- production in p p ¯ collisions at s =0.9 and 1.96 TeV at CDF MEASUREMENT of CENTRAL EXCLUSIVE π+π- ... T. AALTONEN et al

D. Whiteson, T. Aaltonen, M. Albrow, 2015 .

Combination of measurements of the top-quark pair production cross section from the Tevatron Collider

D. Whiteson, T. Aaltonen, S. Amerio, 2013, 1309.7570.